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5. GENERAL INTRODUCTION
5.1 Ocular Surface
The term ‘ocular surface’, initially introduced by Thoft (1977), encompass the conjunctival 
and corneal epithelia, each of which has a distinct cellular phenotype. They interact and are 
both crucial for maintaining a healthy ocular surface and preventing blindness. The corneal 
and conjunctival epithelial cells form the ocular surface, which is covered by the tear film 
(Fig. 1). Conjunctival and corneal epithelia undergo continuous replacement by dividing and 
differentiating cells. The epithelial cells originate from stem cell populations in each tissue.
Figure 1. The ocular surface is covered by conjunctival and corneal epithelial cells. Both 
epithelia are covered by the tear film. The superior and inferior conjunctival epithelium can 
be divided into a forniceal, bulbar and tarsal part. Adapted from Gaffney et al. 2010. 
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5.2 The conjunctiva
5.2.1 The Conjunctival Epithelium
5.2.1.1 Structure
Conjunctival epithelium is non-keratinized and is at least two cell layers thick (Wagoner, 
1997). It consists of two phenotypically distinct cell types –stratified squamous non-goblet 
cells (90 – 95%) and goblet cells (5 – 10%) (Fig. 2), in addition to occasional lymphocytes 
(Dua et al., 1994a; Steven and Gebert, 2009) and melanocytes (Latkovic and Nilsson, 1979). 
The conjunctival epithelium can anatomically be divided into three parts: 1) the tarsal (or 
palpebral) conjunctiva, which covers the backside of the eyelids; 2) the bulbar conjunctiva, 
which covers the anterior surface of the globe, except the cornea; and 3) the forniceal 
conjunctiva, which connects the bulbar and tarsal conjunctiva (Fig. 1).
5.2.1.2 Function
The conjunctival epithelium plays an important role in ensuring the optical clarity of the 
cornea by providing lubrication to maintain a smooth, refractive surface and by producing 
mucins critical for tear film stability (Wagoner, 1997; Schrader et al., 2009b). The conjunctiva 
also protects the eye against mechanical stress and infectious agents. It furthermore 
contributes water and electrolytes to the tear fluid (Yu et al., 2012). The squamous cells 
produce cell membrane spanning mucins, while the goblet cells secrete the gel forming 
mucins, both of which helps to maintain a protective tear film.
5.2.2 The Stratified Squamous Non-goblet Cells
5.2.2.1 Morphology and Identification
The squamous cells are flattened cells (Fig. 2) that cover the larger part of the conjunctival 
surface. In contrast to the goblet cells, the stratified squamous cells express cytokeratin 4 
(CK4) (Kasper, 1991). The cells are connected together apically by zonulae occludens (tight 
junctions) and desmosomes (Weyrauch, 1983a). The superficial surface of the squamous cells 
are covered by the membrane-tethered mucins mucin-1 (MUC1), mucin-4 (MUC4) and 
mucin-16 (MUC16) (Gendler and Spicer, 1995; Govindarajan and Gipson, 2010).
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5.2.2.2 Function
The membrane-tethered mucins MUC1, MUC4 and MUC16 are essential for tear stability and 
make up the innermost layer the tear film (Fig. 7) (Gendler and Spicer, 1995; Gipson et al., 
2004; Govindarajan and Gipson, 2010). The squamous cells also contribute to the hydration 
of the ocular surface through ion transport across the apical cell membrane with 
accompanying osmotic water transfer (Yu et al., 2012). The forniceal region may be 
especially important as it has reportedly higher ion transport activity than the bulbar and 
palpebral region (Yu et al., 2012).
Figure 2. Photomicrograph of cross-sectioned haematoxylin and eosin (H&E)-stained rat 
conjunctiva showing goblet cells (black arrowheads) and stratified squamous non-goblet cells 
(white arrowheads). The conjunctival epithelium rests on the conjunctival basement 
membrane (BM) (dotted line). The loose, vascularized conjunctival stroma is situated beneath 
the BM. Original magnification: ⨉630.
5.2.3 The Goblet Cells
5.2.3.1 Morphology and Identification
Goblet cells contain mucin-granules (Fig. 2-4) and have traditionally been identified through 
their secretory product using markers including the Ulex europaeus agglutinin-1 (UEA-1) 
lectin, anti-mucin-5AC (MUC5AC) antibody and Periodic acid-Schiff (PAS) reagent that 
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target the goblet cell gel-forming mucins (Fig. 3) (Kawano et al., 1984; Argueso and Gipson, 
2001). 
Figure 3. Conjunctival goblet cells identified by Periodic acid-Schiff (PAS) reagent, Ulex 
europaeus agglutinin-1 (UEA-1) and mucin-5AC (MUC5AC) staining. (A) Cross-section of 
PAS-stained whole rat eye showing the inferior forniceal sac (*) with numerous PAS+ 
(purple) goblet cells (G) in the fornix. Original magnification: ⨉40. (B) Immunofluorescence 
image displaying rat conjunctiva with UEA-1-stained goblet cell mucin (green). (C) 
Immunofluorescence image showing MUC5AC+ (green) goblet cells. (B and C) Cell nuclei 
were stained with 4',6-diamidino-2-phenylindole (DAPI) (blue). The white dotted line 
indicates the approximate position of the basal membrane. Magnification: ⨉630. Scale bars: 
100 µm.
In haematoxylin and eosin (H&E)-stained sections the goblet cells can be easily identified 
through their mucin content (Fig. 2). With transmission electron microscopy (TEM), each 
single mucin vesicle can be discerned, often containing a central electron dense spot (Fig. 4). 
25
As opposed to the squamous cells the goblet cells can be identified by specific anti-
cytokeratin 7 (CK7) antibody clones (Kasper, 1991). In the clinic, the identification of goblet 
cells with impression cytology (Fig. 14B) (Tseng, 1985) or in vivo confocal microscopy 
(IVCM) (Dua et al., 2009) is one of the key diagnostic features of limbal stem cell deficiency 
(LSCD) (Fig. 14A). 
Figure 4. Transmission electron photomicrographs showing conjunctival goblet cells with 
characteristic perinuclear mucin vesicles. (A) Cultured human conjunctival epithelial cells. 
Original magnification: ⨉3400. Scale bar: 10 µm. (B) Cultured rat conjunctival epithelial 
cells. Original magnification: ⨉6000. Adapted from Shatos et al. 2001. (V) Goblet cell mucin 
vesicles.
5.2.3.2 Regulation
The MUC5AC, or gel-forming mucin, is secreted by goblet cells into the tear film by 
exocytosis upon stimulation of the goblet cells by contact with exogenous neurotransmitters 
or through activation of a neural reflex arc involving sensory afferent fibers from the cornea 
and conjunctiva and parasympathetic efferent fibers that surround the goblet cells (Fig. 5) 
(Dartt et al., 1995; Kessler et al., 1995; Dartt et al., 1996; Rios et al., 1999; Kanno et al., 
2003; Dartt et al., 2011; Hayashi et al., 2012). The goblet cell secretion can also be stimulated 
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by the gastro-protective drug OPC-12759 (Rios et al., 2008). The production of the goblet cell 
specific mucin MUC5AC is induced by fibroblast growth factor 10 (FBF10) (Ma et al., 2011) 
and regulated by vitamin A (Driot and Bonne, 1992; Tei et al., 2000). The packing of mucin 
within goblet cells prior to exocytosis is dependent on a physiological level of calcium (Paz et 
al., 2003).
Figure 5. The neural regulation of goblet cells. Activation of a complex neural reflex arc 
involving corneal and conjunctival sensory afferent fibers and parasympathetic efferent fibers 
stimulates the goblet cells to secrete the gel-forming mucin-5AC (MUC5AC) into the tear film 
by exocytosis. From Dartt et al. 2004. 
5.2.3.3 Function
The goblet cells secrete MUC5AC into the aqueous part of the tear film (Spurr-Michaud et al., 
2007). This mucin type prevents the formation of an irregular tear film that would scatter the 
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light upon entering the eye (Spurr-Michaud et al., 2007), thereby maintaining visual acuity. 
The secreted MUC5AC also entraps and removes particles from the ocular surface (Adams, 
1979) and aids in the spreading of tears on the ocular surface, thereby inhibiting the 
development of dry spots (Lemp et al., 1970; Holly and Lemp, 1971; Lemp and Hamill, 
1973). Secretion of MUC5AC by the goblet cells has also been reported to regulate ocular 
surface inflammation and inhibit symptoms of dry eye disease (DED) (Contreras-Ruiz et al., 
2012).
5.2.3.4 Location
In the human fetus goblet cells first appear in the fornix after nine weeks of gestational age 
(Miyashita et al., 1992) and later extend on to the palpebral and bulbar conjunctiva. Several 
studies have demonstrated that fornix contains the highest number of goblet cells (Moore et 
al., 1987; Huang et al., 1988; Goller and Weyrauch, 1993; Lavker et al., 1998; Fostad et al., 
2012). There is a tendency for a higher goblet cell concentration in the inferior conjunctiva 
compared to the superior (Moore et al., 1987; Fostad et al., 2012). 
 Recently, Panjoohesh-Ganji et al. reported the identification of corneal goblet cells in 
a mouse model (Pajoohesh-Ganji et al., 2012). These goblet cells were located at the limbal-
corneal junction and were, as opposed to conjunctival goblet cells, cytokeratin 12 (CK12)+, 
which the authors claim indicates corneal origin. 
5.2.3.5 Differentiation
The differentiation of conjunctival goblet cells depends on numerous factors, including 
transcription factors (Ueta et al., 2005; Swamynathan et al., 2007; Swamynathan, 2010; Gupta 
et al., 2011; Kenchegowda et al., 2011), interleukin-13 (De Paiva et al., 2011), vitamin A 
(Tseng and Farazdaghi, 1988; Driot and Bonne, 1992), the substrate (Tsai and Tseng, 1988), 
number of cell doublings (Pellegrini et al., 1999), cell environment (Meller et al., 2002), 
conjunctival fibroblasts (Tsai et al., 1994) and growth factors (Li et al., 2010). Proliferation of 
goblet cells can be increased by the gastroprotective drug OPC-12759 (Rios et al., 2006). The 
goblet cell density show positive correlation with tear osmolarity in healthy subjects, but not 
in cases with hyperosmolar tear fluid (Julio et al., 2012).
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5.2.4 The Conjunctival Basement Membrane
The conjunctival basement membrane (BM) is a thin connective tissue membrane, which is 
composed of collagen type IV (collagen α1 and α2 chains), laminin (α5, β2 and g1 chains), 
nidogen-1 and -2 and thrombospondin-4 (Schlotzer-Schrehardt et al., 2007).
5.2.5 The Conjunctival Stroma
The conjunctival stroma is made up of a densely vascularized loose connective tissue (Fig. 2) 
(Schrader et al., 2009b). It contains lymphoid tissue (conjunctiva-associated lymphoid tissue; 
CALT) (Knop and Knop, 2000; Steven and Gebert, 2009), which contributes to the defense 
against intrusion of ocular surface pathogens (Knop and Knop, 2003). Conjunctiva-associated 
lymphoid tissue develops during childhood and can be identified in healthy adult individuals 
(Wotherspoon et al., 1994).
5.3 The Cornea
5.3.1 Structure and Composition
The cornea consists of five layers including, from outermost to innermost: epithelium, 
Bowman’s membrane, stroma, Descemet’s membrane and endothelium (Fig. 6). The corneal 
epithelium consists of five to six layers of stratified squamous, non-keratinized (Tseng et al., 
1984) epithelial cells with a turnover period of four to six days (Hanna and O'Brien, 1960; 
Hanna et al., 1961). In the limbal region, the epithelium is thicker and comprises about ten 
cell layers (Wagoner, 1997). The stroma represents a dense collagenous tissue, which makes 
up 90% of the corneal thickness.
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Figure 6. Corneal histology. (1) Epithelium, (2) Bowman’s membrane, (3) stroma, (4) 
Descemet’s membrane and (5) endothelium. From Mission for vision (http://
www.images.missionforvisionusa.org/anatomy/2005/10/cornea-histology.html). 
5.3.2 Function
The corneal epithelium protects against infection, oxidative stress (Kovaceva et al., 2007), 
stromal scarring and perforation (Jeng, 2006). The stroma interacts with the corneal 
epithelium (Mishima and Hedbys, 1967; Johnson-Muller and Gross, 1978; Johnson-Wint, 
1980; Johnson-Wint and Gross, 1984; Johnson-Wint and Bauer, 1985; Strissel et al., 1995) 
and its highly regular structure makes the cornea transparent (Hassell et al., 1983). The 
endothelial cell layer pumps fluid out of the stroma, which is necessary for the maintenance of 
a clear cornea (Trenberth and Mishima, 1968).
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5.4 The Tear Film
5.4.1 Structure and Composition
The tear film covers the ocular surface and fills the conjunctival forniceal sacs (Fig. 1). The 
mean total tear fluid is estimated to approximately 6-10 µl (Mishima et al., 1966; Tiffany, 
2008). The tear menisci, which are visible upon fluorescein staining (Fig. 13), contain 
approximately 2.9 µl fluid (Bron et al., 2002). The meniscus curvature radius correlates with 
the total tear volume (Yokoi et al., 2004). The normal preocular tear film is 3-10 μm thick 
(Tiffany, 2008) and can be divided into several layers: 1) the glycocalyx; 2) inner mucous; 3) 
middle aqueous; and 4) outer lipid (Fig. 7). Multiple models have been suggested for the 
structure of the tear film, most based on the three layers proposed by Wolff (1946). Originally, 
these three layers consisted of an inner gelatinous mucus layer (subsequently modified to 
include the glycocalyx), middle aqueous layer and an outer Meibomian lipid layer. More 
recently, a two-layer model devoid of a free aqueous layer was presented for rats and mice. 
The two-layer model consists of an outer lipid layer and an inner aqueous layer that is mixed 
with mucous so that there is no clear separation between the mucous and aqueous 
compartments (Chen et al., 1997; Tran et al., 2003). So far, no consensus has been reached 
regarding which model best describes the human tear film. 
Figure 7. The layers of the tear film. The tear film covers the ocular surface and can be 
divided into the glycocalyx, inner mucous, middle aqueous and outer lipid layer. From 
Nichols et al. 2011.  
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5.4.2 Function
The tear film lubricates the ocular surface, ensures an optically smooth cornea by removing 
minute irregularities, provides nutrition (Fatt and Bieber, 1968; Tiffany, 2008), protects 
against oxidants (Crouch et al., 1991), promote epithelial healing (Haynes et al., 1999), acts as 
a pH buffer (Yamada et al., 1998) and defends the ocular surface against pathogens 
(Brauninger et al., 1972; Adams, 1979; Haynes et al., 1999; Fluckinger et al., 2004; Paulsen, 
2008; Tiffany, 2008; Garreis et al., 2011). 
5.4.3 The Glycocalyx and Inner Mucous Layer
The tear film stability depends on the ocular surface mucins, microvilli and glycocalyx. 
Mucins produced by conjunctival epithelial cells are either secreted directly into the tear film 
(MUC5AC), or membrane tethered on the tips of the microvilli, thereby participating in the 
formation of the glycocalyx (Fig. 8) and promoting tear film stability (Dartt, 2004; Gipson, 
2004, 2007). External domains of the membrane tethered mucins can be released into the tear 
film by enzymatic action at the cleavage site (Lillehoj et al., 2003; Thathiah et al., 2003; 
Govindarajan et al., 2012). The mucins are glycosylated glycoproteins that cover the apical 
surface of the superficial cells (Gendler and Spicer, 1995). The main membrane-tethered 
mucins of the ocular surface consist of MUC1, MUC4 and MUC16 (Govindarajan and 
Gipson, 2010), of which the maintenance of MUC16 is dependent on Notch signaling (Xiong 
et al., 2011).
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Figure 8. Transmission electron photomicrograph showing the apical surface of a cultured 
human conjunctival epithelial cell with numerous microvilli (Mv) covered with a faint gray 
“coating”, the glycocalyx (Gc). Original magnification: ⨉9700. Scale bar: 2 µm.
5.4.4 The Middle Aqueous Layer
The aqueous part of the tear film represents the major component of tears and contains 
electrolytes, water, peptides (e.g., defensins (Haynes et al., 1999)), glycopeptides and proteins 
such as lysozyme, lactoferrin, lipocalin, secretory IgA, growth factors (van Setten et al., 1994; 
Tiffany, 2008) and mucins. The mucins in the aqueous layer comprise mucin-7 (MUC7) 
(Jumblatt et al., 2003; Paulsen, 2006; Dartt, 2009), MUC5AC and membrane-tethered mucins 
originating from shed ocular surface cells or released by ectodomain shedding (Spurr-
Michaud et al., 2007; Govindarajan et al., 2012). 
 While the lacrimal glands are responsible for the major portion of the aqueous tear 
film, the corneal (Tiffany, 2008) and conjunctival epithelium participates directly to the 
hydration of the ocular surface by ion transport across the apical cell membrane with 
accompanying osmotic water transfer (Yu et al., 2012). The tear volume at any given time is 
dependent on the rate of tear influx (from the lacrimal gland (Fig. 9) and ocular surface 
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epithelium) and outflux (via the lacrimal puncta (Fig. 9) and tear evaporation) (Tiffany, 2008). 
The secretion by the lacrimal gland show diurnal variation, with a lower secretion rate during 
sleep (Tiffany, 2008).
5.4.5 The Superficial Lipid-layer
The superficial portion of the tear film consists of a lipid bilayer (Fig. 7) (McCulley and 
Shine, 1997), secreted from the Meibomian glands in the eyelids (Fig. 1 and 10). This layer 
stabilizes the tear film by decreasing tear evaporation (Tiffany, 1985; Nichols et al., 2011) and 
regulating the surface tension (Lozato et al., 2001). The thin inner polar layer consists of 
phospholipids (phosphatidylcholine and phosphatidylethanolamine), free fatty acids and 
cholesterol esters (Tiffany, 2008). The thick outer non-polar layer is dependent on the inner 
polar layer and comprises wax esters (fatty acids and long-chain fatty alcohol) and cholesterol 
esters (McCulley and Shine, 1997). In a tear film lipid layer (TFLL) model, the wax esters 
were found to be the most important evaporation-retardants (Rantamaki et al., 2012). The 
lipid layer is susceptible to temperature changes and at sub-physiological temperatures the 
lipids stiffens and shrinks, in which case the middle aqueous layer becomes exposed through 
gaps in the lipid layer (Butovich et al., 2010).
5.5 The Lacrimal Apparatus
5.5.1 Structure
The lacrimal apparatus comprises the lacrimal glands (the main and accessory lacrimal glands 
(Allansmith et al., 1976; Gillette et al., 1980; Tiffany, 2008)), lacrimal puncta/canaliculi, 
lacrimal sac and the nasolacrimal duct (Fig. 9). The lacrimal gland is a tubuloacinar, mixed 
seromucous gland (Prince, 1977), including acinar, ductal and myoepithelial cells (Dartt, 
2009). This gland is located in the lacrimal fossa of the orbital region.
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Figure 9. Tear fluid is mainly produced and drained by the lacrimal gland apparatus, which is 
composed of the main lacrimal gland, the accessory lacrimal glands, the lacrimal puncta, the 
lacrimal canaliculi, the lacrimal sac and the nasolacrimal duct. Adapted from Gaffney et al. 
2010. 
5.5.2 Functions
The main function of the lacrimal gland apparatus is to produce and drain tear fluid (Fig. 9). 
The lacrimal gland secretes the major part of the aqueous layer of the tear film, in addition to 
proteins (Dartt and Hodges, 2011), mucins (the secretory mucin MUC7 (Jumblatt et al., 2003; 
Paulsen, 2006; Dartt, 2009)) and electrolytes (Dartt, 2009). The secretory mucin-5B 
(MUC5B) has also been detected in the lacrimal gland (Jumblatt et al., 2003).
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5.5.3 Regulation
The lacrimal gland is under strict neuronal control. Afferent sensory nerve fibers from the 
cornea and conjunctiva are coupled with efferent sympathetic and parasympathetic nerves that 
stimulate the lacrimal gland (Dartt, 2009). The acinar cells are the main secretory cells, 
however, the ductal cells secrete about 30% of the fluid (Mircheff, 1983) and can modify the 
protein and electrolyte content of the tear fluid (Ubels et al., 1994; Hodges and Dartt, 2003). 
The myo-epithelial cells, which can be identified by their expression of α-smooth muscle 
actin (α-SMA) (Ohtomo et al., 2011), surround the acinar and ductal cells (Dartt, 2009).
5.5.4 Lacrimal Gland Disease
The lacrimal gland contains progenitor cells that are capable of differentiating into several 
separate cell lineages (Shatos et al., 2012). This may partly explain why the lacrimal gland to 
a certain extent can regenerate upon damage (Zoukhri et al., 2007; Zoukhri et al., 2008). The 
lacrimal gland can be damaged by a number of causes, including autoimmune diseases, viral 
infections and trauma (Zoukhri, 2006), which subsequently lead to aqueous deficient dry eye 
(ADDE) (DEWS, 2007).
5.6 The Meibomian Glands
5.6.1 Structure
The Meibomian glands, first described in 1666 (Meibom), are sebaceous glands situated in 
the tarsal plate of the eye lids (Fig. 10A) (Nichols et al., 2011). Each gland consists of 
meibocytes with several acini, central and lateral ductules and a terminal excretory duct 
ending that deliver the secretion (meibum) to the lid margin (Fig. 10B) (Nichols et al., 2011). 
The upper eyelid contains 30-40 glands and the lower lid has 20-30 glands (Lawton, 1998). 
The Meibomian secretions contain polar and non-polar lipids and comprise of a complex 
mixture of different lipids (Pes, 1897; Tiffany, 1987), including wax esters, (O-Acyl)-omega-
hydroxy fatty acids and cholesterol esters (Butovich, 2011).
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Figure 10. The Meibomian glands can be seen macroscopically on the inside of the eyelid as 
white stripes (A, arrows). Meibomian secretions (B, arrow) on the posterior edge of the 
eyelid. Adapted from Butovich et al. 2011. 
5.6.2 Functions
The Meibomian glands secrete lipids and proteins onto the eyelid margins (Fig. 10B), forming 
the superficial layer of the tear film and thereby inhibiting tear evaporation (Tiffany, 1985; 
Nichols et al., 2011). The Meibomian gland secretions also aid in preserving a clear optical 
surface and protect against ocular surface pathogens (Garreis et al., 2011).
5.6.3 Regulation
Although the lipids are formed continuously (Butovich, 2011), the output from the glands 
may be affected by systemic hormones, age (Chew et al., 1993a), sex (Chew et al., 1993a) and 
by mechanical stimulation such as eye blinking (Tiffany, 2008). The contraction and 
relaxation of the orbicularis oris muscle in the eyelids during eye blinking not only promotes 
secretion of meibum stored in the large excretory ducts, but also removes the old secretions at 
the same time (Khanal and Millar, 2010).
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5.6.4 Meibomian Gland Dysfunction
Meibomian gland dysfunction (MGD) (Fig. 12A) is the most common cause of DED (Nichols 
et al., 2011). It is a chronic, diffuse disorder of the Meibomian glands that leads to terminal 
duct obstruction with or without changes in the glandular secretions (Fig. 12B) (Nichols et al., 
2011). In some patients the number of Meibomian glands can be visibly decreased (McCann 
et al., 2009). 
5.7 Regenerative Medicine and Tissue Engineering
5.7.1 Definitions
A short definition of ‘regenerative medicine’ was suggested by Mason and Dunnill (2008): 
 “Regenerative medicine replaces or regenerates human cells, tissues or organs, to 
 restore or establish normal function.” 
‘Tissue engineering’, on the other hand, a more narrow term first coined by Fung in 1987 
(Viola et al., 2003), does not encompass the regeneration of cells and tissues in vivo, but 
rather the process of developing functional substitutes ex vivo for damaged tissues (Langer 
and Vacanti, 1993). Transplanted cells, tissues or organs used for regenerative purposes can be 
‘autologous’ (originating from the patient), thereby avoiding immuno-rejection, or 
‘allogeneic’ (from another human), which necessitates immunosuppressive therapy.
5.7.2 Historical Overview
Currently estimated to be beneficial to one third of the population (Harris et al., 2007), 
regenerative medicine has developed tremendously since its early period in the beginning of 
the 20th century. Corneal transplantation, in 1924 described by Sir John Parsons in his 
ophthalmology textbook as being “practically never successful” (Parsons, 1924), is now the 
most frequently performed transplantation, with almost 50.000 operations annually in the U.S. 
alone (EBAA, 2010). Although the first successful corneal transplantation was performed as 
early as in 1905 (Zirm, 1906), considerable progress within the field of organ transplantation 
was first made in the 1950s and 60s, with the first kidney (Murray and Holden, 1954), bone 
marrow (Thomas et al., 1957), lung (Hardy et al., 1963), liver (Starzl et al., 1968) and heart 
(Cooper, 2001) transplantations. However, it was the discovery of the immunosuppressive 
drug cyclosporin A in a soil sample from Hardangervidda in Norway in 1969 (Svarstad et al., 
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2000) that transformed transplantation surgery from experimental science into life-saving 
procedures (Borel et al., 1976). Cyclosporin A has later proven crucial for the first successful 
combined heart-lung transplantations in 1981 (Jamieson et al., 1983). The development of 
improved immunosuppressive regimens and the success of modern transplantation surgery 
have later dramatically increased the demand for donor organs. This, in addition to the 
continued challenge of allograft rejection, in spite of immunosuppressive medication, has lead 
to immense interest in fields such as tissue engineering.
 Tissue engineering enables researchers to expand the harvested cells ex vivo prior to 
transplantation, thereby limiting donor site damage and potentially avoiding the need for 
organ transplantation. Using epidermis, which share many similarities with the conjunctival 
epithelium, Billingham and Reynolds demonstrated in 1952 the principle of expanding cells 
ex vivo before applying them to a graft bed in an animal model to restore the epidermis 
(Billingham and Reynolds, 1952). During the 60s and 70s the ex vivo culture technique was 
improved by the advent of culture medium growth factors (Cohen, 1986) and the co-culture 
technique (Rheinwald and Green, 1975), which enabled the expansion of a sufficient number 
of cells for transplantation. The first human therapy with cultured cells was performed in 
1980 when two third degree burn patients were treated with autologous epidermal cultures 
(O'Connor et al., 1981; Green, 2008). In 1993, Lindberg showed that cultured human limbal 
epithelial cells (HLEC) could be transplanted to nude mice (Lindberg et al., 1993) and four 
years later Pellegrini et al. reported the first successful transplantation of cultured HLEC for 
corneal surface restoration in LSCD (Pellegrini et al., 1997). Finally, in 2000, the first 
transplantation of cultured human conjunctival epithelial (HCjE) cells to restore a diseased 
conjunctiva was reported (Scuderi et al.).
5.8 Stem Cells - Definition and Basic Principles
Edmund Beecher Wilson first introduced the English term “stem cell” in 1896, possibly 
inspired by Valentin Haecker’s use of “Stammzelle” (cells that give rise to the germline). 
Today, a stem cell is defined by its capacity to 1) self-renew and 2) produce cells that 
differentiate (Morrison and Kimble, 2006). 
 Stem sells can either divide symmetrically or asymmetrically (Morrison and Kimble, 
2006). In asymmetric cell division, each stem cell divides to generate one daughter cell that is 
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programmed to become a stem cell (self-renewal) and one daughter cell that will differentiate 
(Fig. 11). Symmetric cell division is defined as the generation of daughter cells that are 
destined for the same fate. 
 Stem cells can be categorized in terms of their potency and their origin. Totipotent 
stem cells are able to form entire organisms, while others can only form a single cell lineage 
(“unipotent” stem cells). Stem cells may originate from embryos (human embryonic stem 
cells; hESC (Brivanlou et al., 2003)); fetal or adult tissue (Atala, 2012); amniotic fluid 
(amniotic fluid stem cells (AFSC) (De Coppi et al., 2007)); generated through somatic cell 
nuclear transfer (SCNT) (Hochedlinger et al., 2004); or induced from adult somatic cells 
(induced pluripotent stem cells (iPSC) (Takahashi and Yamanaka, 2006; Teoh and Cheong, 
2012)). The difference between a stem cell and a progenitor cell is not easily demonstrated in 
the laboratory as both cells may give rise to several different lineages (Grompe, 2012). Still, 
true stem cells should be capable of self-renewal for the life-time of the individual, while 
progenitor cells eventually cease to replicate (Grompe, 2012).
 Typically, putative stem cells have been attempted identified through their proposed 
ability to multiply for an indefinite time, as well as their slow cycling nature in vivo. While 
the capability of cell division can be assessed by in vitro colony-forming assays (Barrandon 
and Green, 1987), the identification of slow cycling (‘label-retaining’) cells can be performed 
by administration of radioactive thymidine or 5-bromo-2'-deoxyuridine (BrdU), which 
incorporates into the deoxyribonucleic acid (DNA), followed by a label “washout” period to 
remove thymidine or BrdU from cycling cells (Potten and Hendry, 1975). Putative stem cells 
are considered to be able to divide for an extended time and generate large ‘holoclones’ in 
vitro (Barrandon and Green, 1987). In vivo, the stem cells are considered to divide 
infrequently in order to conserve their DNA, thus they are thought to be label-retaining even 
after several months of label washout.
 More recent studies using cell lineage tracing (Grompe, 2012; Kretzschmar and Watt, 
2012), a technique where the progeny of a specific stem, progenitor or differentiated cell can 
be traced in vivo, have yielded surprising results indicating that some tissues harbor more than 
one stem cell compartment (Li and Clevers, 2010). Co-existing stem cell compartments have
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Figure 11. Stem cells can divide asymmetrically or symmetrically. In the first case they give 
rise to one stem cell and one cell that is destined to differentiate. When dividing symmetrically 
the stem cell produces two new stem cells. Courtesy of Håkon Raanes, The Oslo School of 
Architecture and Design, Norway.
now been detected in several tissues, including intestinal epithelium (Barker et al., 2007; 
Snippert et al., 2010b), epidermis (Cotsarelis et al., 1990; Jaks et al., 2010; Snippert et al., 
2010a), liver (Duncan et al., 2009; Dorrell et al., 2011) and muscle (Tedesco et al., 2010). 
Other tissues, on the other hand, may not contain stem cells at all. In the endocrine pancreas 
cell lineage tracing studies have showed that the insulin+ β-cells in adult mice do not develop 
from insulin- stem cells, rather they are generated by the pre-existing insulin+ cells (Dor et 
al., 2004). 
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5.9 Conjunctival Stem Cells
Conjunctival stem cells continuously regenerate the conjunctiva by giving rise to both 
stratified squamous non-goblet and goblet cells (Wei et al., 1997; Pellegrini et al., 1999), 
thereby maintaining a healthy tear film (Mason et al., 2011). Disorders that damage these 
stem cells cause varying extents of keratinization, which disrupts the protective tear film and 
ultimately lead to LSCD and visual impairment or blindness. 
5.9.1 Location
The location of the conjunctival stem cells has been a matter of controversy. Conjunctival 
epithelial stem cells have been suggested to reside in the limbus (rat (Pe'er et al., 1996)), 
bulbar conjunctiva (mouse (Nagasaki and Zhao, 2005) and human (Pellegrini et al., 1999; Qi 
et al., 2010)), forniceal conjunctiva (rabbit (Wei et al., 1993), mouse (Wei et al., 1995; Lavker 
et al., 1998) and human (Pellegrini et al., 1999)), palpebral conjunctiva (rat (Chen et al., 
2003)) and mucocutaneous junction (rat (Pe'er et al., 1996) and rabbit (Wirtschafter et al., 
1999)).
5.9.2 Characterization
Putative conjunctival stem cells may be identified by immunomarkers, colony-forming 
efficiency (CFE) (Pellegrini et al., 1999; Schrader et al., 2010; Su et al., 2011), BrdU label-
retaining cells (Su et al., 2011), cell movement (Su et al., 2011), microarray gene analysis 
(Akinci et al., 2009) and based on the success of conjunctival transplantations (Tsubota et al., 
2002).
5.9.2.1 Putative Immunomarkers for Conjunctival Epithelial Progenitor Cells
Possible markers of conjunctival progenitor cells include ATP-binding cassette sub-family G 
member 2 (ABCG2) (Budak et al., 2005; Schrader et al., 2010; Pauklin et al., 2011), tumor 
protein p63 (p63) (Vascotto and Griffith, 2006; Rosellini et al., 2007; Pauklin et al., 2011), 
p63α (Schrader et al., 2010), cytokeratin 5 (CK5) (Liu et al., 2007), cytokeratin 8 (CK8) (Liu 
et al., 2007), cytokeratin 10 (CK10) (Rosellini et al., 2007), cytokeratin 13 (CK13) (Rosellini 
et al., 2007), cytokeratin 15 (CK15) (Schrader et al., 2010; Pauklin et al., 2011), β1-integrin 
subunit (CD29) (Vascotto and Griffith, 2006), tumor necrosis factor receptor family-5 
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(TNFR5/CD40) (Vascotto and Griffith, 2006), hyalunorate receptor (CD44) (Vascotto and 
Griffith, 2006), muscarinic reseptor subtype m3 (Liu et al., 2007), nestin (Rosellini et al., 
2007), tyrosine kinase receptor A (TrkA) (Qi et al., 2010), nerve growth factor (NGF) (Qi et 
al., 2010), glial cell-derived neurotrophic factor (GDNF) (Qi et al., 2010), GDNF family 
receptor α-1 (GFRα-1) (Qi et al., 2010), neurotrophin low-affinity receptor (NTR) p75 (Qi et 
al., 2010), epidermal growth factor receptor (EGFR) (Vascotto and Griffith, 2006) and 
integrin β-1, α-enolase (Qi et al., 2010). In addition to the presence of stem cell markers, 
conjunctival epithelial stem cells are devoid of differentiation-associated markers, such as 
cytokeratin 4 (CK4) (Kasper, 1991), MUC5AC (Argueso and Gipson, 2001) and UEA-1 
(Table 1) (Shatos et al., 2001).
Table 1 Immunocharacterization of Conjunctival Epithelial Cells
Epithelial 
location
Marker Cell type Reference
Basal ATP-binding cassette sub-
family G member 2 (ABCG2)
Progenitor cells (Budak et al., 2005)
Tumor protein p63 (p63) Progenitor cells (Rosellini et al., 
2007)
p63α Progenitor cells (Schrader et al., 
2010)
Cytokeratin 5 (CK5) Progenitor cells (Liu et al., 2007)
Cytokeratin 8 (CK8) Progenitor cells (Liu et al., 2007; 
Merjava et al., 
2011a)
Cytokeratin 10 (CK10) Progenitor cells (Rosellini et al., 
2007)
Cytokeratin 15 (CK15) Progenitor cells (Schrader et al., 
2010)
β1-integrin subunit (CD29) Progenitor cells (Vascotto and 
Griffith, 2006)
Tumor necrosis factor receptor 
family-5 (TNFR5/CD40)
Progenitor cells (Vascotto and 
Griffith, 2006)
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Epithelial 
location
Marker Cell type Reference
Hyalunorate receptor (CD44) Progenitor cells (Vascotto and 
Griffith, 2006)
Muscarinic reseptor subtype 
m3
Progenitor cells (Liu et al., 2007)
Nestin Progenitor cells (Rosellini et al., 
2007)
Tyrosine kinase receptor A 
(TrkA)
Progenitor cells (Qi et al., 2010)
Nerve growth factor (NGF) Progenitor cells (Qi et al., 2010)
Glial cell-derived neurotrophic 
factor (GDNF)
Progenitor cells (Qi et al., 2010)
GDNF family receptor α-1 
(GFRα-1)
Progenitor cells (Qi et al., 2010)
Neurotrophin low-affinity 
receptor (NTR) p75
Progenitor cells (Qi et al., 2010)
Epidermal growth factor 
receptor (EGFR)
Progenitor cells (Vascotto and 
Griffith, 2006)
Integrin β-1, α-enolase Progenitor cells (Qi et al., 2010)
Cytokeratin 7 (CK7) Goblet cells (Kasper, 1991)
Mucin-5AC (MUC5AC) Goblet cells (Argueso and 
Gipson, 2001)
Ulex europaeus agglutinin-1 
(UEA-1)
Goblet cells (Shatos et al., 2001)
Proliferating cell nuclear 
antigen (PCNA)
Proliferating cells (Eidet et al., 2012a)
Ki67 Proliferating cells (Nishida et al., 
1999)
Suprabasal p63 Progenitor cells (Qi et al., 2010)
CK7 Goblet cells (Kasper, 1991)
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Epithelial 
location
Marker Cell type Reference
MUC5AC Goblet cells (Argueso and 
Gipson, 2001)
UEA-1 Goblet cells (Shatos et al., 2001)
Cytokeratin 16 (CK16) (Merjava et al., 
2011b)
Superficial CK4 Stratified squamous 
non-goblet cells
(Kasper, 1991)
CK7 Goblet cells/
stratified squamous 
non-goblet cells
(Kasper, 1991; 
Jirsova et al., 2011; 
Merjava et al., 
2011b)
MUC5AC Goblet cells (Argueso and 
Gipson, 2001)
UEA-1 Goblet cells (Shatos et al., 2001)
5.9.2.2 Genes Associated with Conjunctival Epithelial Progenitor Cells
Microarray analysis has demonstrated upregulation of Msh homeobox (MSX), MEIS, ID, 
hairy and enchancer of split-1 (HES1), sina oculis (SIX), cytochrome P450, family 1, 
subfamily A, polypeptide-1 (CYP1A1), dual specificity phosphatases (DUSPs), paired box 
protein 6 (PAX6) and CD62 antigen-like family member E (CD62E) in conjunctival side 
population cells, which may represent conjunctival stem cells (Akinci et al., 2009). 
Polymerase chain reaction (PCR) analysis detected similar expression of the stem cell-related 
genes for CK15, p63, Tír inna n-Óc (NANOG), octamer-binding transcription factor 4 
(OCT4), sex determining region Y (SRY)-box 2 (SOX2), KIT, Krüppel-like factor 4 (KLF4), 
Notch homolog 1 (NOTCH1) and nestin in human bulbar and forniceal conjunctiva (Pauklin 
et al., 2011). In the latter study, only ABCG2 of the assayed stem cell related genes was more 
expressed in fornix compared to bulbus.
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5.9.2.3 Colony-forming Efficiency
The CFE assay is used to estimate the percentage of seeded cells that are able to form 
colonies in culture, an estimate which is indicative of the number of putative stem cells in the 
given cell sample. Su and co-workers compared the CFE of the palpebral, forniceal and 
bulbar conjunctiva and found that the palpebra yielded the highest CFE (Su et al., 2011). 
Others have found a uniform distribution of colony-forming cells throughout the superior and 
inferior fornix and bulbus, as well as the nasal and temporal bulbus of a single patient 
(Pellegrini et al., 1999). According to size, the colonies can be identified as holoclones, 
meroclones and paraclones; the holoclones are considered to result from putative stem cells 
(Barrandon and Green, 1987; Majo et al., 2008). The latter colonies are rapidly growing and 
the largest. Meroclones, which are intermediate in size, consist of both growing and terminal 
colonies. The paraclones are the smallest, which include only terminal colonies with highly 
limited growth potential.
5.9.2.4 5-bromo-2'-deoxyuridine Labelling
As described in section 5.8, label-retaining cells are considered to be quiescent stem cells. 
They have been identified in the palpebral conjunctiva of rabbits (Budak et al., 2005; Su et al., 
2011) and Wistar rats (Chen et al., 2003), the fornix of rabbits (Budak et al., 2005) and at the 
mucocutaneous junction of rabbits (Wirtschafter et al., 1997; Wirtschafter et al., 1999). 
Nagasaki et al., though only investigating the bulbar conjunctiva, found that label-retaining 
cells were uniformly distributed throughout the bulbar region of mice (2005). The number of 
label retaining cells, or putative conjunctival stem cells, has been reported to be decreased in 
DED (Chen et al., 2007).
5.9.2.5 Cell Movement
Analogous to the centripetal movement of the corneal epithelial cells from the limbus to the 
center of the cornea (Hanna, 1966; Buck, 1979; Auran et al., 1995; Collinson et al., 2002; 
Nagasaki and Zhao, 2003), the migration of cells within the conjunctival epithelium has also 
been investigated to determine the location of the conjunctival stem cells. Nagasaki et al. 
found no cell movement in the bulbar region and suggested the stem cells were uniformly 
distributed in the bulbus (Nagasaki and Zhao, 2005). In a controversial article, Majo and co-
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workers, on the other hand, suggested that bulbar conjunctival epithelial cells move towards 
the limbus (2008). This was later strongly rejected by Sun and associates who claimed that 
conjunctival cells do not migrate, at least not towards the limbus (2010). In a short-term BrdU 
label-retaining study in rabbits, label-retaining cells were identified progressively further from 
the mucocutaneous junction and closer to the fornix after one, three and five days. The 
authors, therefore, suggested that transiently amplifying cells (TAC) move from the stem cell 
rich mucocutaneous junction to the fornix (Wirtschafter et al., 1997). Recently, a nearly 
identical experiment, also in rabbits, has confirmed the study by Wirtschafter et al. (Su et al., 
2011). 
5.9.2.6 Clinical Observations
Tsubota and co-workers reported successful conjunctival restoration after transplantation of a 
limbal-conjunctival (bulbar and forniceal conjunctiva) allograft in a nine-year old patient with 
total keratinization of the ocular surface due to Stevens-Johnson syndrome (SJS) (Tsubota et 
al., 2002). This could indicate that conjunctival epithelial stem cells reside in either bulbus or 
fornix.
5.10 Corneal Stem Cells
The corneal epithelium is replenished by the limbal stem cells (LSC) that give rise to highly 
proliferative daughter cells that migrate centripetally and differentiate before being shed from 
the surface of the cornea (Schermer et al., 1986; Thoft et al., 1989; Kruse et al., 1990; 
Lindberg et al., 1993). 
5.10.1 The Limbal Dogma
The corneal stem cells have long been considered to be located in the limbal region, more 
specifically at the palisades of Vogt (Davanger and Evensen, 1971). In this location the LSC 
are close to blood vessels (Van Buskirk, 1989) and are protected against shearing forces 
(Gipson, 1989). More recently, the limbal crypts, extending from the palisades of Vogt, have 
been suggested as a niche for LSC (Dua et al., 2005; Shanmuganathan et al., 2007) due to 
expression of putative stem cell markers. In 2008, Majo and associates questioned the limbal 
dogma by reporting that corneal epithelial cells from several different species were capable of 
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generating holoclones, which are considered a stem cell characteristic (Majo et al., 2008). 
This finding, however, has been controversial and while having some support (Dua et al., 
2009), others argue that the finding of putative stem cells in the central cornea was caused by 
the use of corneas from young children and non-human species, but not adult human corneas 
(Sun et al., 2010).
5.10.2 Characterization
Several different methods, including immunostaining, CFE assays and label-retaining assays, 
have been used to try to identify putative limbal stem cells. A great number of potential stem 
cell markers have been proposed, however, no specific marker of LSC has been detected so 
far. Currently, LSC can be indicated by the presence of the putative stem cell markers ABCG2 
and ΔNp63α, combined with the absence of differentiation markers, including cytokeratin 
3/12 (CK3/12) (de Paiva et al., 2005; Di Iorio et al., 2005; Schlotzer-Schrehardt and Kruse, 
2005). 
5.11 Ocular Surface Stem Cell Niche
Stem cells are surrounded, and affected, by a three-dimensional microenvironment known as 
a niche (Schofield, 1983; McNairn and Guasch, 2011; Ordonez and Di Girolamo, 2012). The 
niche comprises of numerous components, including stromal cells, soluble factors, 
extracellular matrix (ECM), mechanical/spatial cues and signaling molecules that dictates 
stem cell function (Watt and Hogan, 2000; Scadden, 2006; Jones and Wagers, 2008). 
 Stem cell niches have been localized for several different types of stem cells, including 
haematopoietic stem cells (HSC) (Calvi et al., 2003; Zhang et al., 2003; Kiel et al., 2005), 
neural stem cells (NSC) (Doetsch et al., 1999; Palmer et al., 2000), epidermal stem cells 
(Watt, 2002; Tumbar et al., 2004), intestinal stem cells (ISC) (Barker et al., 2007), 
spermatogonial stem cells (SSC) (Chiarini-Garcia et al., 2003; Yoshida et al., 2007), skeletal 
muscle stem cells (Collins et al., 2005; Kuang et al., 2007) and LSC (Dua et al., 2005; 
Shanmuganathan et al., 2007). As mentioned in section 5.9.1, the location of conjunctival 
stem cells and thereby their niche, are still a matter of controversy, however. The limbal stem 
cell niche has been reported to contain specific ECM proteins (Schlotzer-Schrehardt et al., 
2007). Moreover, the specific composition of the ECM reportedly show topographical 
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variations throughout the ocular surface (Schlotzer-Schrehardt et al., 2007). Thus, there may 
also exist differences in the composition of the ECM across the conjunctiva, which affect the 
location of the conjunctival stem cells. Secretion of hormones from stromal cells, such as 
fibroblast growth factor 10 (FGF10) has been shown to induce the production of the mucins 
MUC1, MUC4 and mucin-5 (MUC5), as well as stimulate growth, of conjunctival epithelial 
cells (Ma et al., 2011). In vitro simulation of the conjunctival epithelial niche using co-
cultures with human bulbar subconjunctival fibroblasts did also support more conjunctival 
epithelial progenitor cells than co-cultures with conventional fibroblasts (3-day transfer, 
inoculum 3 x 105 cells; 3T3) (Schrader et al., 2010). Recently, Schrader and co-workers 
reported that conjunctival fibroblasts might enhance the maintenance of conjunctival 
epithelial progenitor cells by regulating the activation of the Wnt pathway (Schrader et al., 
2012a). In another study, co-cultures with conjunctival fibroblasts reportedly induced the 
development of more goblet cells than co-cultures with 3T3 fibroblasts (Tsai et al., 1994). 
Hence, the conjunctival stem cell niche may be influenced by the topographical differences in 
the ECM and the secretion of fibroblast growth factor (FGF) from subconjunctival fibroblasts.
5.12 Ocular Surface Disease
A wide variety of diseases and injuries can affect the ocular surface and cause different 
degrees of inflammation, scarring and/or tissue loss. The main ocular surface disorders that 
are of particular interest to regenerative ophthalmology are described below. 
5.12.1 Dry Eye Disease
Dry eye disease is a multifactorial disorder involving a dysfunctional tear film and 
abnormalities in the ocular surface (DEWS, 2007). 
5.12.1.1 Symptoms
The occurrence of symptoms, which indicates activation of sensory nerves at the ocular 
surface (Belmonte et al., 2004), include feeling of ocular dryness, foreign body sensation and 
irritation, light sensitivity and visual disturbance (Rieger, 1992; Liu and Pflugfelder, 1999; 
Goto et al., 2002; Begley et al., 2003; Adatia et al., 2004; Vitale et al., 2004). 
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5.12.1.2 Signs
Signs of DED depends on the underlying cause and may include decreased tear break-up time 
(TBUT), decreased tear meniscus height (Fig. 13), decreased Schirmer’s test score, 
Meibomian gland dysfunction (MGD) with impaired meibum expression and/or meibum 
quality (Fig. 12), conjunctival injection (Fig. 12), conjunctival and/or corneal staining, 
keratitis, corneal ulceration, mucous clumping, increased tear film debris (Holly, 1973; Bron, 
2001; Goto et al., 2003), trichiasis, sympblepharon and ocular surface keratinization (DEWS, 
2007).
Figure 12. Photomicrographs showing a patient with dry eye disease due to aquous deficiency 
and Meibomian gland dysfunction. (A) The eyelid margins are slightly inflamed (arrow). 
Characteristic dry eye-related hyperemia in the form of a horizontal band over the 
conjunctiva limited to the interpalpebral fissure can also be seen. (B) When assuming gentle 
pressure on the eyelid the Meibomian glands extrude pathological toothpaste-like secretions. 
Courtesy of Dr. Sten Raeder, MD, PhD, Tørreøyneklinikken, Oslo, Norway (http://
torreoyneklinikken.no).
5.12.1.3 Prevalence
The global prevalence of DED is 5-35% (DEWS, 2007) and the prevalence increases with 
age. Hence it is expected that this disease will affect an even bigger group in the years to 
come as the population above 50 years old increases (Schaumberg et al., 2001). 
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5.12.1.4 Etiology
Dry eye disease can be subdivided into an aqueous deficient type and evaporative type 
(DEWS, 2007). The former can be further separated into dry eye caused by Sjögren’s 
syndrome and non-Sjögren’s syndrome (Feltsan et al., 2012). Besides lacrimal deficiency 
(Scherz and Dohlman, 1975), the non-Sjögren’s group includes primary (formerly denoted 
“Keratoconjunctivitis sicca” (KCS)) (Mathers et al., 1996) and secondary (Scherz and 
Dohlman, 1975) lacrimal gland deficiency, as well as cases with lacrimal gland obstruction 
caused by scarring ocular surface diseases, such as trachoma (Guzey et al., 2000), cicatrizing 
conjunctival disease (Dart, 2005; Eschle-Meniconi et al., 2005; Hingorani and Lightman, 
2006), erythema multiforme/SJS/toxic epidermal necrolysis (TEN) (Power et al., 1995) and 
chemical/thermal burns (Lemp, 1992). Also included in the non-Sjögren group are cases with 
hyposecretion due to for example adverse effects of systemic drugs (Moss et al., 2004). 
 The evaporative type includes those caused by intrinsic and extrinsic factors. The 
intrinsic causes are represented (most often) by MGD (Foulks and Bron, 2003; Bron and 
Tiffany, 2004; Bron et al., 2004; Nichols et al., 2011), in addition to defective lid/globe 
interaction leading to an exposed evaporative surface (Lemp, 1973) and low blink rate 
(Abelson et al., 2002). There are numerous extrinsic causes that mainly lead to dry eye 
through damage to the ocular surface corneal and conjunctival goblet/non-goblet cells, which 
again lead to imperfect surface wetting and destabilization of the tear film. Such extrinsic 
disorders include vitamin A deficiency (Tei et al., 2000; Hori et al., 2004), chronic ocular 
surface diseases (DEWS, 2007) and allergic conjunctivitis (Abelson et al., 2003). In addition, 
environmental factors, such as low relative humidity, can also cause tear film parameters 
similar to those of DED patients (Abusharha and Pearce, 2012). For any of the above 
mentioned causes of dry eye, there may be a concomitant loss of goblet cell numbers, which 
further aggravate symptoms (Ralph, 1975a).
5.12.1.5 Pathogenesis
Although still largely unknown, the pathogenesis of DED includes an inflammatory 
component (Pflugfelder et al., 1999; Tsubota et al., 1999), involving the mitogen-activated 
protein kinase (MAPK) (Luo et al., 2005) and nuclear factor-kβ (NF-kβ) pathway (Lan et al., 
2012), that is activated upon tear film instability and tear hyperosmolarity (Gilbard, 1994; 
Murube, 2006; Tomlinson et al., 2006; Stevenson et al., 2012). Secretion of pro-inflammatory 
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cytokines (Cejkova et al., 2007b) cause oxidative stress (Cejkova et al., 2007a) and lead to 
squamous metaplasia and a decrease in the differentiation of goblet cells (De Paiva et al., 
2007; Chen et al., 2010). During the course of the disease the epithelial cell density and 
thickness increases (Fabiani et al., 2009). Goblet and non-goblet conjunctival cells are also 
lost due to induction of apoptosis (Yeh et al., 2003), where the loss of goblet cells can be seen 
as a result of chronic conjunctival inflammation (Kunert et al., 2002). Expression of the 
goblet cell secreted MUC5AC is reduced in dry eye (Zhao et al., 2001; Argueso et al., 2002) 
and glycosylation of MUC16 is changed in non-Sjögrens dry eye (Gipson et al., 2004). Thus, 
a diseased conjunctival epithelium, including alterations in both the secreted and membrane 
bound mucins, is an important contributing factor to tear film instability in DED.
5.12.1.6 Diagnostic Tests
The tear film can be analyzed be means of its stability (Lemp and Hamill, 1973), volume 
(Schirmer, 1903; Jones, 1966; Kurihashi, 1976; Yokoi et al., 1999) (Fig. 13), osmolarity 
(Pensyl and Benjamin, 1999), completeness (Feenstra and Tseng, 1992), quality (Norn, 1994), 
evaporation rate (Mathers et al., 1993) and physical properties (Tiffany et al., 1989; Tiffany, 
1991). The Meibomian gland output can be objectively measured by meibometry (Chew et 
al., 1993a; Chew et al., 1993b). Dry eye associated cell morphology characteristics can be 
visualized by impression cytology and IVCM (Kojima et al., 2010).
 Based on the severity of symptoms and signs DED patients can be grouped into four 
levels (DEWS, 2007). Treatment will then be tailored according to the severity level.
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Figure 13. Fluorescein staining of the tear fluid can be used to assess the tear film and tear 
volume. In cases of decreased tear production (A) the tear meniscus height (green) is <100 
µm and less than in healthy eyes (B). Adapted from Koh et al. 2006. 
5.12.1.7 Treatment Options
Treatment depends on the level of disease severity (Table 2) (DEWS, 2007). Severe DED (i.e. 
level 4) may benefit from transplantation of a conjunctival tissue substitute.
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Table 2 - Treatment Modalities According to Severity Level of Dry Eye Disease (DED)
Level 1 Education and dietary adjustments (Tsubota and Nakamori, 1993; 
Barabino et al., 2003)
Eliminating adverse medications (Mader and Stulting, 1991)
Artificial tear substitutes, gels and 
ointments
(Gilbard et al., 1989)
Eyelid therapy (DEWS, 2007)
Level 2 Topical anti-inflammatories (Laibovitz et al., 1993; Gunduz and 
Ozdemir, 1994; Pflugfelder et al., 
2004)
Tetracyclines (Jansen and Plewig, 1997)
Punctal plugs (Foulds, 1961)
Tear stimulation (Tauber et al., 2004)
Moisture chamber spectacles (Gresset et al., 1984)
Level 3 Serum eye drops (Noble et al., 2004; Kojima et al., 
2005; Jirsova et al., 2008)
Contact lenses (Bacon et al., 1994; Pullum et al., 
2005)
Permanent punctal occlusion (Beetham, 1935)
Level 4 Systemic anti-inflammatory agents (DEWS, 2007)
Surgery: lid surgery; mucous 
membrane, salivary gland and amniotic 
membrane transplantation.
(Geerling et al., 1998)
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5.12.2 Limbal Stem Cell Deficiency
5.12.2.1 Definition
A hallmark of LSCD is conjunctivalization of the cornea (Fig. 14A) (Tseng, 1989). The 
diagnosis can be made clinically (Schwartz and Holland, 2005), by impression cytology (Fig. 
14B) (Egbert et al., 1977; Thiel et al., 1997) or by IVCM (Dua et al., 2009; Vera et al., 2009; 
Zheng et al., 2009; Nubile et al., 2012).
Figure 14. Limbal stem cell deficiency (LSCD). (A) Clinically, LSCD can be diagnosed by 
ingrowth of conjunctival cells resulting in an opaque, vascularized cornea. (B) Impression 
cytology of the cornea of a patient with LSCD showing a Periodic acid-Schiff (PAS)+ (arrow) 
goblet cell. Adapted from Sangwan et al. 2012 and Garcia et al. 2012. 
5.12.2.2 Etiology
Limbal stem cell deficiency may be primary, as in aniridia, more commonly however, it is 
secondary to external damaging processes, of which chemical burns are most usually the 
cause (Table 3) (Dua et al., 2000). The stem cell deficiency may be diffuse, covering the 
entire cornea, or partial, affecting only a sector of the cornea (Dua et al., 2000).
55
Table 3 Etiology of Limbal Stem Cell Deficiency (LSCD)
Idiopathic (Espana et al., 2002a)
Hereditary Aniridia (Nishida et al., 1995)
Congenital aniridia variant: minimally 
abnormal irides with severe limbal stem 
cell deficiency (LSCD)
(Skeens et al., 2011)
Dominantly inherited keratitis (Kivlin et al., 1986)
Autosomal dominant keratitis (Pearce et al., 1995)
Multiple endocrine neoplasia (MEN) (Puangsricharern and Tseng, 
1995)
Ectrodactyly-ectodermal dysplasia-
clefting syndrome
(Di Iorio et al., 2012)
Ectodermal dysplasia syndrome (Anderson et al., 2003)
Keratitis-icthyosis-deafness syndrome 
(KID syndrome)
(Gicquel et al., 2002; 
Messmer et al., 2005)
Xeroderma pigmentosa (Fernandes et al., 2004)
Lacrimo-auriculo-dento-digital syndrome 
(LADD syndrome or Levy-Hollister 
syndrome)
(Cortes et al., 2005; Inan et 
al., 2006)
Autoimmune polyendocrinopathy-
candidiasis-ectodermal dystrophy 
(APECED)
(Tarkkanen and Merenmies, 
2001)
Bilateral LSCD with chromosomal 
translocation of 3p and 9p
(Usui et al., 2010)
Epidermolysis bullosa (EB) dystrophica 
hallopeau-Siemens
(Thanos et al., 2010)
Iris coloboma (Espana et al., 2002c)
Dyskeratosis congenital (Aslan and Akata, 2010)
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Table 3 Etiology of Limbal Stem Cell Deficiency (LSCD)
Gelatinous drop-like dystrophy (Shimazaki et al., 2002)
Trauma Chemical and thermal burn (Rama et al., 2010)
Sulfur-mustard (Kadar et al., 2009; Kadar et 
al., 2011)
Delayed-onset mustard gas keratitis (Pleyer et al., 1999; Javadi et 
al., 2005; Javadi et al., 2011)
Eye disease Pterygium (Kwok and Coroneo, 1994; 
Mahdy and Bhatia, 2009)
Pseudopterygium (Vemuganti et al., 2009)
Neurotrophic keratitis (Puangsricharern and Tseng, 
1995)
Infections (including trachoma) (Dua and Azuara-Blanco, 
1999; Holland and Schwartz, 
1999; Schwab et al., 2000; 
Kremer et al., 2009; 
Ledbetter et al., 2012)
Atopy (Tsai et al., 1990)
Sclerocornea (Tsai and Tseng, 1994)
Keratoconjunctivitis sicca (KCS) (Vemuganti et al., 2009)
Vernal keratoconjunctivitis, 
keratoconjunctivitis
(Gomes et al., 2009; 
Sangwan et al., 2011b)
Tumors (Vemuganti et al., 2009)
Corneal intraepithelial dysplasia (Tan et al., 1996)
Peripheral ulcerative keratitis (Mooren’s 
ulcer)
 Peripheral ulcerative 
keratitis (Mooren’s ulcer)
Bullous keratopathy (Satake et al., 2009)
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Table 3 Etiology of Limbal Stem Cell Deficiency (LSCD)
Limbal dermoid (Hong et al., 2010)
Iatrogenic Multiple ocular surface operations (Holland and Schwartz, 
1997; Schwartz and Holland, 
1998, 2001)
Multiple intravitreal injections (Capella et al., 2011)
Cryotherapy (Puangsricharern and Tseng, 
1995)
Phototherapeutic keratectomy (Nghiem-Buffet et al., 2003; 
Cannon et al., 2004)
Radiotherapy (Fujishima et al., 1996; 
Smith et al., 2000)
Contact lens use (Clinch et al., 1992; Jenkins 
et al., 1993; Bhatia et al., 
2009)
Topical treatment with cytostatic drugs 
and mitomycin-C
(Pires et al., 2000; Dudney 
and Malecha, 2004; Sauder 
and Jonas, 2006; Lichtinger 
et al., 2010)
Systemic chemotherapy (Ellies et al., 2001; Solomon 
et al., 2002; Ding et al., 
2009)
Ultraviolet radiation (Di Girolamo et al., 2002)
Posttreatment for recurrent ocular surface 
melanoma
(Di Girolamo et al., 2009)
Systemic Graft-versus-host disease (GVHD) (Sale et al., 1994; Meller et 
al., 2009)
Vitamin A deficiency (Vemuganti et al., 2009)
58
Table 3 Etiology of Limbal Stem Cell Deficiency (LSCD)
Immune-
mediated
Stevens-Johnson syndrome (SJS) (Puangsricharern and Tseng, 
1995)
Ocular cicatricial pemphigoid (OCP) (Dua, 1995; Elder et al., 
1996; Dua et al., 2000)
Multiple endocrine deficiency (Mohammadpour et al., 
2006)
5.12.2.3 Symptoms
Symptoms of LSCD include epiphora, irritation, blepharospasm, photophobia, pain and 
decreased visual acuity (Dua and Azuara-Blanco, 2000).
5.12.2.4 Signs
Depending on the severity of the LSCD, signs include loss of palisades of Vogt (Schwartz and 
Holland, 2005), late epithelial staining with fluorescein (Dua et al., 1994b), corneal 
vascularization (Holland, 1996), peripheral pannus (Dua and Azuara-Blanco, 2000; Dua et al., 
2000), punctate epithelial keratopathy, epithelial defects, corneal ulceration and perforation, 
conjunctivalization (Kruse et al., 2003) and finally epithelial keratinization and stromal 
scarring.
5.12.2.5 Treatment
Limbal stem cell deficiency is mainly treated by surgical means. In addition, eye drops (Poon 
et al., 2001; Geerling et al., 2004; Young et al., 2004; Jeng et al., 2011), insertion of scleral 
lenses (Schornack, 2011) and recently, even the application of pulsed electromagnetic fields 
may be attempted (Rezaei Kanavi et al., 2012). An important surgical treatment of LSCD is 
the use of keratoprosthesis (Dohlman et al., 2005). Several other surgical procedures have 
been developed, including sequential sector conjunctival epitheliectomy (SSCE) (Dua, 1998; 
Dua et al., 2010), keratolimbal allograft (KLAL) (Holland, 1996), conjunctival limbal 
autograft (CLAU) (Kenyon and Tseng, 1989; Holland, 1996), living-related conjunctival 
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limbal allograft (lr-CLAL) (Holland, 1996), homologous penetrating central limbo-
keratoplasty (HPCLK) (Reinhard et al., 1999; Reinhard et al., 2004; Spelsberg et al., 2004; 
Egarth et al., 2005) and amniotic membrane transplantation (AMT) (Kim and Tseng, 1995; 
Tseng et al., 1998; Pires et al., 2000; Anderson et al., 2001; Gomes et al., 2003; Sangwan et 
al., 2004).
 The replacement of the limbal stem cells by transplantation of ex vivo cultured limbal 
cells has been much explored and is successful in approximately three out of four cases 
(Pellegrini et al., 1997; Schwab, 1999; Schwab et al., 2000; Tsai et al., 2000; Koizumi et al., 
2001a, b; Rama et al., 2001; Grueterich et al., 2002; Tseng et al., 2002; Nakamura et al., 
2003b; Sangwan et al., 2003a; Sangwan et al., 2003b; Harkin et al., 2004; Nakamura et al., 
2004b; Daya et al., 2005; Sangwan et al., 2005; Nakamura et al., 2006b; Sangwan et al., 2006; 
Ang et al., 2007; Fatima et al., 2007; Kawashima et al., 2007; Shimazaki et al., 2007; Shortt et  
al., 2008; DeSousa et al., 2009; Di Girolamo et al., 2009; Gomes et al., 2009; Meller et al., 
2009; Baradaran-Rafii et al., 2010; Colabelli Gisoldi et al., 2010; Di Iorio et al., 2010; Kolli et 
al., 2010; Meller et al., 2010; Nakamura et al., 2010; Pauklin et al., 2010; Rama et al., 2010; 
Thanos et al., 2010; Sangwan et al., 2011a; Sharma et al., 2011; Marchini et al., 2012; 
Shigeyasu and Shimazaki, 2012). Recently, Sangwan et al. reported successful treatment of 
unilateral LSCD using a novel technique, ‘simple limbal epithelial transplantation’ (SLET), in 
which a 2x2 mm limbal biopsy from the healthy contralateral eye is divided into eight to ten 
smaller pieces and allowed to grow in vivo on the damaged cornea (Sangwan et al., 2012). 
According to the authors, using SLET will cut laboratory expenses of treating LSCD and 
reduce the risk of infection.
 In addition to using limbal cells, several non-limbal cell types have been attempted, 
including oral mucosal epithelial cells (Nakamura et al., 2003a; Nakamura and Kinoshita, 
2003; Nakamura et al., 2004a; Hayashida et al., 2005; Ang et al., 2006; Inatomi et al., 2006; 
Nakamura et al., 2007; Satake et al., 2008; Chen et al., 2009; Ma et al., 2009; Shimazaki et 
al., 2009; Liu et al., 2011; Nakamura et al., 2011; Priya et al., 2011; Takeda et al., 2011; 
Burillon et al., 2012), conjunctival epithelial cells (Sangwan et al., 2003a; Sangwan et al., 
2003b; Tanioka et al., 2006; Ono et al., 2007; Di Girolamo et al., 2009; Ang et al., 2010), 
embryonic stem cells (ESC) (Homma et al., 2004), bone-marrow-derived mesenchymal stem 
cells (MSC) (Ma et al., 2006; Omoto et al., 2009; Jiang et al., 2010; Reinshagen et al., 2011), 
epidermal epithelial cells (Yang et al., 2007; Yang et al., 2008), immature dental pulp stem 
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cells (Monteiro et al., 2009; Gomes et al., 2010), hair follicle-derived stem cells (Meyer-
Blazejewska et al., 2011) and umbilical cord lining stem cells (Reza et al., 2011). Irrespective 
of the cell type used, however, in the absence of a healthy conjunctiva replacement of limbal 
stem cells are prone to failure (Mason et al., 2011).
5.12.3 Conjunctival Inflammation
5.12.3.1 Etiology
Conjunctival inflammation (conjunctivitis) is the most common cause of red eye and is 
usually caused by self-limiting viral and bacterial infections (Morrow and Abbott, 1998). 
Adenovirus is the major viral culprit (Morrow and Abbott, 1998; Oliver et al., 2009). 
Bacterial conjunctivitis can be hyperacute (within 24 hours of exposure), acute (typically 
lasting seven to ten days) or chronic (lasting more than three weeks) (Morrow and Abbott, 
1998). It is mostly caused by to streptococcus pneumoniae and haemophilus influenzae 
(children), whereas adults are predominantly infected by staphylococcus aureus (Morrow and 
Abbott, 1998; Oliver et al., 2009). Non-infectious conjunctivitis includes self-limiting and 
mild diseases, as well as severe sight-threatening disorders (Table 4).
5.12.3.2 Symptoms
Symptoms are unspecific and include tearing, burning sensation, grittiness and stinging. Pain, 
photophobia and foreign body sensation usually indicate involvement of the cornea.
5.12.3.3 Signs
Signs may include conjunctival injection, chemosis, haemorrhages, pseudomembrane 
formation, infiltration, follicular reaction and subconjunctival scarring (Fig. 15)
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Table 4 - Etiology of Conjunctivitis
Infectious Viral Adenovirus (Skevaki et al., 2011)
Herpes simplex (Skevaki et al., 2011)
Bacterial Staphylococcus aureus (Wright et al., 2008; 
Oliver et al., 2009)
Streptococcus pneumonia (Pichichero, 2011)
Haemophilus species (Pichichero, 2011)
Moraxella (Pichichero, 2011)
Neisseria species (Pichichero, 2011)
Enteric gram-negativ rods (Pichichero, 2011)
Chlamydia trachomatis (Burton, 2007)
Other Fungi (Schubach et al., 2005)
Parasites (Shen et al., 2006)
Non-infectious Allergic Seasonal/perennial allergic 
conjunctivitis
(Stahl and Barney, 
2004)
Atopic keratoconjunctivitis 
(AKC)
(Akova et al., 1994)
Vernal keratoconjunctivitis 
(VKC)
(Kari and Saari, 2012)
Giant papillary conjunctivitis 
(GPC)
(Kari and Saari, 2012)
Immune-
mediated
Ocular cicatricial 
pemphigoid (OCP)
(Nguyen and Foster, 
1996)
Stevens-Johnson syndrome 
(SJS)
(Ignat and Oprescu, 
1989)
 Toxic epidermal necrolysis 
(TEN)
(Prendiville et al., 
1989)
Sjögren’s syndrome (DEWS, 2007)
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Table 4 - Etiology of Conjunctivitis
Miscellaneous Superior limbic 
keratoconjunctivitis
(Cher, 2000)
Foreign body conjunctivitis (Meyer and Tangas, 
2003)
Toxic conjunctivitis (Thygeson, 1957)
Graft-versus-host disease 
(GVHD)
(Townley et al., 2011)
Xeroderma pigmentosa (Hadj-Rabia et al., 
2012)
Meibomian gland 
dysfunction (MGD)
(Nichols et al., 2011)
5.12.3.4 Treatment Options
Treatment depends on the disease etiology and severity, but conservative measures may 
include bandage contact lens (Watson et al., 2002); lid hygiene (Tetz et al., 1997); topical 
application of artificial tears/lubricants (Bielory, 2002a, b), decongestants (Wallace et al., 
2008), mast cell stabilizers (Gokhale et al., 2012), antihistamines (McCabe and McCabe, 
2012), nonsteroidal anti-inflammatory drugs (NSAIDs) (Bielory, 2007, 2008), antibiotics 
(Sheikh et al., 2012), steroids (Bielory and Friedlaender, 2008; Oner et al., 2012), mitomycin 
C (MMC) (Jain and Sukhija, 2006) or immunosuppressive/modulating drugs (Kheirkhah et 
al., 2011; Meyer-Rusenberg et al., 2011; Garnock-Jones, 2012; Gonzalez-Lopez et al., 2012; 
Turan-Vural et al., 2012); systemic administration of antibiotics (Poli et al., 2010), 
antihistamines (Bhargava et al., 1998; Butrus and Portela, 2005), immunosuppressive drugs 
(Poli et al., 2010; Gokhale et al., 2012); environmental improvement; and reduction of 
transmission through hygienic measures (Meyer-Rusenberg et al., 2011).
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Figure 15. Photomicrographs showing signs of conjunctival inflammation, including (A) 
follicular reaction, (B) conjunctival injection, (C) chemosis, (D) subconjunctival hemorrhage, 
(E) pseudomembrane and (F) subconjunctival scarring. Adapted from Burton and Mabey 
2009; Engin et al. 2009; Jabs et al. 1989; Torkildsen 2005; and Vose et al. 2006. 
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5.12.4 Conjunctival Scarring
5.12.4.1 Etiology
A large number of disorders can lead to scarring of the conjunctiva (Table 5). Scarring varies 
in severity and can be self-limited, such as in infectious diseases due to adeno- and herpes 
viruses, or progressive, as in ocular cicatricial pemphigoid (OCP).
Table 5 - Etiology of Severe Conjunctival Scarring
Immune-mediated Ocular cicatricial pemphigoid 
(OCP)
(Nguyen and Foster, 1996)
Stevens-Johnson syndrome 
(SJS)
(Ignat and Oprescu, 1989; 
Prendiville et al., 1989)
 Toxic epidermal necrolysis 
(TEN)
(Prendiville et al., 1989; 
Magina et al., 2003)
Sjögren syndrome (McCarthy, 1988)
Trauma Injuries (Kaufman and Thomas, 1979)
Chemical/thermal burns (Zurabov, 1956)
Allergy Atopic keratoconjunctivitis 
(AKC)
(Akova et al., 1994)
Iatrogenic Eye lid surgery (Tarr and Constable, 1980; 
Miller and Boynton, 1987)
Infections Herpesvirus (Andrew, 2001)
Adenovirus (epidemic 
keratoconjunctivitis; EKC)
(Hammer et al., 1990)
Trachoma (Pavisic, 1953)
Systemic diseases Epidermolysis bullosa (EB) (Letko et al., 2006)
Graft-versus-host disease 
(GVHD)
(Allan et al., 2011)
Sarcoidosis (Flach, 1978)
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5.12.4.2 Pathogenesis
Ocular surface mucin expression may increase initially especially in cases of allergic 
conjunctivitis (Foster et al., 1986; Kunert et al., 2001), however, in later stages alterations in 
mucin biosynthesis (Argueso et al., 2003) and loss of goblet cells (Nelson and Wright, 1984) 
lead to decreased surface wetness with the development of dry eye as described above 
(section 5.12.1). During the course of chronic inflammation the conjunctiva becomes 
keratinized with expression of epidermal epithelial cytokeratin 1 (CK1) and CK10 (Nakamura 
et al., 2001). Symblepharon, which represents shortening or obliteration of the fornices, may 
develop with resulting concomitant ineffective blinking and lagophthalmos (Fig. 16) 
(Solomon et al., 2003). This aggravates the ocular surface damage, causing persistent 
epithelial defects (PED) (Fu et al., 2012) and worsening the tear film instability due to 
obliteration of the normal tear meniscus and distortion of the eye lid/globe interaction. 
Extensive symblepharon may even cause restrictive diplopia (Casas et al., 2008).
Figure 16. Chronic conjunctival inflammation can lead to a dry keratinized conjunctiva (A) 
and the formation of symblepharon (B), the latter in which case the eyelid becomes adherent 
to the sclera. Adapted from Hsu et al. 2012 and Kheirkhah et al. 2012. 
5.12.4.3 Treatment
Depending on the disease etiology, conservative treatment options may include those 
mentioned in section 5.12.3.4. For controlling complications of conjunctival scarring, surgery 
can be considered. Surgical treatment of symblepharon includes removal of the scar tissue to 
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reestablish the deep fornix (Solomon et al., 2003). The surgical defect is then covered by the 
application of a tissue substitute. This is usually followed by different means to prevent re-
obliteration. These include the application of different mechanical (Ralph, 1975b; Choy et al., 
1977; Patel et al., 1998), physical (Fein, 1979) or chemical (Donnenfeld et al., 1999) means, 
or by grafting of conjunctival or mucous membrane (McCarthy, 1988; Solomon et al., 2003).
5.13 Surgical Restoration of the Conjunctiva
Surgical techniques for restoration of a diseased conjunctiva have utilize different 
conjunctival substitutes, although most studies have employed oral mucosal autografts and 
AM, either separately or combined (Table 6).
5.13.1 Pre-surgery Considerations
Chronic inflammation may adversely affect the outcome of conjunctival surgery (Schrader et 
al., 2009b). Thus, prior to surgery measures must be taken to control inflammation, e.g. by 
postponing surgery until inflammation has subsided after chemical burns (Kheirkhah et al., 
2012) or by administering systemic immunosuppressive medication in cases of cicatrizing 
disease (Kheirkhah et al., 2012). In addition, severe dry eye decreases the chance of 
successful surgery and should be alleviated by e.g. punctal occlusion (Kheirkhah et al., 2012).
5.13.2 Post-surgery Considerations
Post-operative medications for patients receiving autologous tissue may include topical 
lubricants, antibiotics, autologous serum and steroids (Pauklin et al., 2010; Kheirkhah et al., 
2012). Patients treated with allogeneic tissue in addition receive systemic immunosuppressive 
medication, such as cyclosporin, tacrolimus (Pauklin et al., 2010; Holland et al., 2012) and 
prednisone (Holland et al., 2012). Outcome evaluation encompasses regular post-operative 
check-ups with e.g. slitlamp examinations, determination of visual acuity and fluorescein 
staining of the ocular surface to assess integrity.
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Table 6 - Transplanted Tissue Substitutes in Conjunctival Disorders
Tissue substitute Disorder
Conjunctival graft Pterygium (Vastine et al., 1982; 
Dayanir et al., 2009; 
Kawano et al., 2011)
Hard palate mucosal graft Malignant tumors of the 
eyelids
(Ito et al., 2001; Ito et al., 
2007)
Oral mucosal graft Ocular cicatricial pemphigoid 
(OCP)
(Shore et al., 1992)
Trachoma (Hosni, 1974)
Trauma (Karesh and Putterman, 
1988)
Nasal mucosal graft Chemical and thermal burns (Kuckelkorn et al., 1996; 
Wenkel et al., 2000)
Neurodermatitis (Wenkel et al., 2000)
Ocular cicatricial pemphigoid 
(OCP)
(Wenkel et al., 2000)
Stevens-Johnson syndrome 
(SJS)
(Wenkel et al., 2000)
Systemic cicatricial mucosal 
disease
(Wenkel et al., 2000)
Toxic epidermal necrolysis 
(TEN)
(Wenkel et al., 2000)
Tenon sheets Chemical and thermal burns (Kuckelkorn et al., 1995)
Venous wall graft Malignant tumors of the 
eyelids
(Barbera et al., 2008)
Amniotic membrane (AM) 
and conjunctival graft
Mooren’s ulcer (Chen et al., 2004)
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Table 6 - Transplanted Tissue Substitutes in Conjunctival Disorders
Tissue substitute Disorder
AM and oral mucosal graft Chemical and thermal burns (Kheirkhah et al., 2012)
Graft-versus-host disease 
(GVHD)
(Kheirkhah et al., 2012)
Mucous membrane 
pemphigoid (MMP)
(Kheirkhah et al., 2012)
Stevens-Johnson syndrome 
(SJS)
(Kheirkhah et al., 2012)
Xeroderma pigmentosa (Kheirkhah et al., 2012)
AM and scleral graft Marfan’s syndrome (Rodriguez-Ares et al., 
1999)
AM with/without oral 
mucosal/conjunctival graft
Chemical and thermal burns (Kheirkhah et al., 2008)
Idiopathic chronic cicatricial 
conjunctivitis
(Kheirkhah et al., 2008)
Malignant tumors of the 
eyelids
(Kheirkhah et al., 2008)
Mucous membrane 
pemphigoid (MMP)
(Kheirkhah et al., 2008)
Multiple previous surgeries (Kheirkhah et al., 2008)
Pseudopemphigoid (Kheirkhah et al., 2008)
Pterygium (Kheirkhah et al., 2008)
Stevens-Johnson syndrome 
(SJS)
(Kheirkhah et al., 2008)
AM Allergic conjunctivitis/hay 
fever
(Solomon et al., 2003)
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Table 6 - Transplanted Tissue Substitutes in Conjunctival Disorders
Tissue substitute Disorder
Chemical and thermal burns (Solomon et al., 2003; 
Tseng et al., 2005)
Dystrophic epidermolysis 
bullosa (EB)
(Goyal et al., 2006)
Junctional EB (Goyal et al., 2006)
Laryngo-onychocutaneous 
(LOGIC) syndrome
(Goyal et al., 2006)
Obstetric trauma (Solomon et al., 2003)
Ocular cicatricial pemphigoid 
(OCP)
(Solomon et al., 2003; 
Tseng et al., 2005)
Pseudopterygium (Tseng et al., 2005)
Pterygium (Solomon et al., 2003; Ang 
et al., 2005; Tseng et al., 
2005)
Stevens-Johnson syndrome 
(SJS)
(Honavar et al., 2000; 
Solomon et al., 2003; 
Tseng et al., 2005)
Strabismus surgery (Solomon et al., 2003)
Superior limbic 
keratoconjunctivitis
(Gris et al., 2010)
Toxic epidermal necrolysis 
(TEN)
(Solomon et al., 2003)
Vernal keratoconjunctivitis 
(VKC)
(Guo et al., 2012)
Autologous conjunctival 
and limbal epithelial cells 
cultured on AM
Limbal stem cell deficiency 
(LSCD) and symblepharon 
due to chemical burn
(Sangwan et al., 2003a)
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Table 6 - Transplanted Tissue Substitutes in Conjunctival Disorders
Tissue substitute Disorder
Autologous conjunctival 
epithelial cells cultured on 
AM
Extensive conjunctival nevus (Tan et al., 2004)
Persistent leaking 
trabeculectomy blebs
(Tan et al., 2004)
Pterygium (Tan et al., 2004; Ang et 
al., 2005)
Recurrent viral papillomata (Ang and Tan, 2005)
Superior limbic 
keratoconjunctivitis
(Tan et al., 2004)
Autologous conjunctival 
epithelial cells cultured 
without AM
Acanthamoeba corneal 
infection with conjunctival 
disepithelialization
(Scuderi et al., 2002)
Congenital divided naevus (Scuderi et al., 2002)
Iatrogenic symblepharon (Scuderi et al., 2002)
Xeroderma pigmentosa (Scuderi et al., 2002)
5.13.3 Tissue Grafts
5.13.3.1 Conjunctival Autografts
Conjunctival autografts has been used to cover small conjunctival defects after removal of 
pterygium (Thoft, 1977; Vastine et al., 1982). Obvious limiting factors when using autografts 
are the size of the defect to be covered as the amount of healthy conjunctiva is limited. In 
addition, in cases where the native conjunctiva is diseased, such as in SJS and OCP, 
harvesting of autografts is not recommended as it may reactivate the disease (Schrader et al., 
2009b). These limitations have led scientists to look for alternative tissues grafts, such as oral 
mucus membrane and nasal mucosa.
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5.13.3.2 Oral Mucous Membrane Grafts
Oral mucosal grafts have been used for reconstruction of the conjunctival fornices (Hosni, 
1974; Shore et al., 1992). Although available in large amounts, the large possibility of donor 
site morbidity, the esthetic discrepancy in thickness and color compared to the conjunctiva 
and the lack of goblet cells in patients with SJS and OCP, are some of the drawbacks.
5.13.3.3 Nasal Mucous Grafts
Nasal mucous grafts have been successfully employed for fornix reconstruction in cases of 
chemical and thermal burns (Kuckelkorn et al., 1996) as well as in patients with OCP (Wenkel 
et al., 2000). One benefit of using nasal mucosa is that it contains a large number of epithelial 
goblet cells. Nasal autografts have reportedly been capable of sustaining goblet cells for ten 
years post-operative (Wenkel et al., 2000). Moreover, the transplanted goblet cells also 
increased ocular surface mucin (Wenkel et al., 2000). Still, the complicated surgical 
harvesting of nasal mucosa, with possibly grave donor site morbidity, prevents nasal mucosa 
autografts from being widely used.
5.13.4 Tissue Engineered Conjunctival Substitutes
A tissue engineered conjunctival epithelial transplant needs to be easily manipulated 
surgically, must not cause an inflammatory reaction and has to be biocompatible. So far, 
conjunctival epithelial cells cultured on AM have been considered the most promising (Ang et 
al., 2005; Schrader et al., 2009b).
5.13.4.1 Ex Vivo Expansion of Conjunctival Epithelial Cells
Although conjunctival epithelial cells have been cultured in the laboratory for at least more 
than 50 years (Cieciura et al., 1956), the culture of conjunctival epithelial cells is still a 
challenge due to the specialized goblet cells. In paper II we show that differentiated mucin-
producing goblet cells generally do not migrate as far from the explant as less differentiated 
goblet cells without mucin production. This loss of mucin-production during cell migration 
from the explant may represent cell dedifferentiation, which is typical of differentiated cells 
initially during primary culture (MacDonald, 1994). Retinal pigment epithelial (RPE) cells, 
another highly specialized ocular epithelium, are also known to dedifferentiate in culture, 
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hence posing some difficulty when attempting to transplant a fully functioning RPE cell sheet 
(Valtink and Engelmann, 2009). For transplantation of LSC, the focus has been on 
transplanting the most undifferentiated cells, as this has been shown to enhance clinical 
outcome (Rama et al., 2010).  No clinical studies have explored the effect of the degree of 
conjunctival transplant differentiation on the clinical outcome.
5.13.4.2 Culture Substrates
The conjunctival phenotype is partly dependent on the substrate. Several studies have 
demonstrated presence of goblet cells when using glass or plastic as substrate (Shatos et al., 
2001; Shatos et al., 2002; Horikawa et al., 2003; Kanno et al., 2003; Shatos et al., 2003; 
Hodges et al., 2007; Gu et al., 2008; Rios et al., 2008; Shatos et al., 2008; Shatos et al., 2009a; 
Shatos et al., 2009b; Dartt et al., 2011). Conjunctival epithelial cells cultured on amniotic 
membrane (AM), however, usually primarily present a non-goblet phenotype (Cho et al., 
1999; Meller and Tseng, 1999; Meller et al., 2002). Our group, on the other hand, detected 
numerous MUC5AC+ superficial cells when using AM (Eidet et al., 2012b). Goblet cells 
have been detected in 3D organotypic cultures on gelatin sponges (Rosellini et al., 2007), 
when culturing conjunctival cells inside type I collagen gels (Niiya et al., 1997) and when 
culturing on top of collagen gels (Tsai and Tseng, 1988). Goblet cells were also seen in 
culture when using Matrigel as substrate, in which case the conjunctival epithelium also 
stratified, as opposed to when using collagen gel substrates (Tsai and Tseng, 1988). Regarding 
the stratified squamous non-goblet conjunctival epithelial cells (which are CK4+), lack of 
laminin β2 in the ECM substrate has been shown to lead to loss of CK4 expression (Kurpakus 
and Lin, 1999). 
5.13.4.3 Explant Culture
Explant culture is a well-established method for studying the conjunctival epithelial cell 
physiology (Diebold et al., 1997). As the explants already contain ECM with growth 
stimulating, subepithelial fibroblasts, cultures are usually not co-cultured with xenobiotic 
feeder cells. This is an advantage when it comes to clinical use, in which case the explant 
method so far has been the only method for culturing conjunctival epithelial transplants (Tan 
et al., 2004; Ang et al., 2005; Di Girolamo et al., 2009). The effects of soluble and insoluble 
ECM factors on the outgrowing cells should, however, be recognized. Our group showed that 
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the size of conjunctival explants affects how effectively the cells grow from the explant, 
which could be related to ECM factors (Eidet et al., 2012a). Human limbal epithelial cells 
reportedly loose stem cell characteristics with increasing distance to the explant (Kolli et al., 
2008). Topographical variations in the composition of the ECM throughout the ocular surface 
(Schlotzer-Schrehardt et al., 2007) may affect the cells when employing explant cultures.
    
5.13.4.4 Cell Culture
For cell culture, cells are initially harvested from their native tissue by the use of different 
enzymes. Chen et al. (2011) demonstrated that complete removal of the ECM from the cells, 
by the use of e.g. dispase, resulted in poorer outgrowth and clonal growth compared the use of 
collagenase, in which case some of the ECM remains. If no specific substrates (see 5.13.4.2) 
or culture techniques (see 5.13.4.6) are used, cell cultures generally do not stratify, as opposed 
to explant cultures. Cell cultures co-cultured with 3T3 fibroblasts may show higher 
mechanical strength than explant cultures due to more desmosomal junctions between cells 
(Koizumi et al., 2002). 
5.13.4.5 Culture Media
Fetal bovine serum (FBS) has traditionally been used as growth supplement in culture media. 
FBS contains vitamin A that has been shown to promote the expression of conjunctival 
epithelial cytokeratins (Fuchs and Green, 1981). There is, however, considerable interest in 
developing animal compound free (ACF) media mostly due to the risk of transmitting 
diseases when using FBS. Culture medium supplemented with umbilical chord blood serum 
(CBS) has been shown to be comparable to media supplemented with FBS in terms of 
supporting proliferative capacity, CFE and number of cell generations (Ang et al., 2011). 
When growing HCjE cells for transplantation, Tan and co-workers employed a serum-free 
culture media (2004). That culture medium, however, was not completely free of animal 
compounds as it contained bovine pituitary extract (BPE).   
5.13.4.6 Air-lifting
Air-lifting has been shown to induce the development of MUC5AC+ goblet cells and 
stratification of HCjE cultures (Meller and Tseng, 1999; Chung et al., 2007; Lee et al., 2011). 
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Others have not found MUC5AC+ goblet cells despite the use of air-lifting (Tanioka et al., 
2006). Cell polarity with microvilli, tight junctions and hemidesmosomes have been shown to 
be more prominent in air-lifted conjunctival cultures (Meller and Tseng, 1999). The molecular 
mechanisms involved in this technique include the p38 mitogen-activated protein kinase and 
Wnt signaling pathways, which were shown to be activated in conjunctival explants cultured 
with an airlift technique (Tan et al., 2011).
5.13.4.7 Feeder Layers
Human conjunctival epithelial cells may be cultured in the presence (Ang et al., 2004; 
Schrader et al., 2009a; Schrader et al., 2012b) or absence (Ang et al., 2004; Nizam et al., 
2008) of a feeder layer. Although a feeder layer is generally considered to increase the 
proliferative capacity of epithelial cells in culture (Rheinwald and Green, 1975), conjunctival 
epithelial cells propagated in serum-free media reportedly demonstrated a similar in vivo 
proliferative capability, as compared to serum-containing media with 3T3 feeder cells (Ang et 
al., 2004). Moreover, co-cultures with human bulbar subconjunctival fibroblasts supported 
more conjunctival epithelial progenitor cells than co-cultures with conventional 3T3 
fibroblasts (Schrader et al., 2010). In the search of a completely ACF culture system, HCjE 
cells cultured with human lung fibroblasts (MRC-5) and 5% human serum displayed similar 
proliferative capacity and number of progenitor cells as conventionally cultured HCjE cells 
(3T3 feeder cells and FBS) (Schrader et al., 2012b).
5.13.4.8 Transplantation of Amniotic Membrane Alone
Seventy years after its first use in ophthalmology, the AM, which constitutes the innermost 
layer of the fetal membranes, has a prominent role in ocular surface reconstruction (Tseng, 
2001). The AM is especially suited for clinical use due to its effects on promoting 
epithelialization (Touhami et al., 2002), reducing scaring (Lee et al., 2000), immune-
suppression (Ueta et al., 2002), pain reduction and decreasing inflammation (Solomon et al., 
2001; Tseng, 2001). Prior to AM transplantation (AMT), the AM is cryopreserved, which kills 
all the AM cells (Kruse et al., 2000). Hence, AM grafts function primarily as a matrix and not 
by virtue of transplanted functional cells. The membranes have most commonly been 
cryopreserved in a basal cell medium at -80°C (Lee and Tseng, 1997), but a technique for 
freeze-drying the AM has also been developed (Nakamura et al., 2004c). Freeze-dried AM 
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can be sterilized by gamma-irradiation (Nakamura et al., 2004c), however, AM treated this 
way may release less amount of growth factors than conventionally cryopreserved membranes 
(Russo et al., 2012). In addition, the AM can be sterilized with peracetic acid/ethanol and air-
dried (von Versen-Hoeynck et al., 2008). The latter technique is, however, reported to yield 
inferior results compared to cryopreserved AM with respect to cell outgrowth rate, release of 
wound-healing factors and preservation of the AM BM (Thomasen et al., 2009). Amniotic 
membrane transplantation can be performed using the AM either as a permanent BM 
substitute with epithelium side facing outwards (e.g. in cases with PED (Seitz, 2007)), as a 
temporary “patch” with the epithelial side facing inwards (e.g. in cases of acute burns (Meller 
et al., 2000)) or by using a combination of the two methods; the sandwich technique (e.g. in 
deep corneal ulcerations (Seitz, 2007)). AM has been used for conjunctival reconstruction 
after complete tumor removal where the AM functions as a BM substitute, promoting wound 
healing by the native conjunctival epithelial cells (Paridaens et al., 2001; Espana et al., 
2002b). It has been suggested as a tissue substitute after removal of conjunctival scars and 
symblepharon, especially when the surrounding conjunctival tissue is close to normal (Tseng 
et al., 1997). In cases with chronic inflammation, however, there is a tendency for recurrent 
shrinkage and symblepharon (Henderson and Collin, 2008). The success of transplanting AM 
is therefore dependent on the underlying disease (Schrader et al., 2009b). 
5.13.4.9 Amniotic Membrane-based Cell Constructs
It has generally been considered that goblet cells do not develop when culturing conjunctival 
cells on AM (Meller and Tseng, 1999; Ang et al., 2010). Our group, however, demonstrated 
large numbers of CK7+/MUC5AC+ goblet cells in the superficial cell layers when using AM 
as culture substrates (Eidet et al., 2012b). Meller and colleagues (2002) showed that although 
mucin-filled (MUC5AC+) goblet cells were undetected in rabbit conjunctival epithelial cells 
cultured on AM, strong PAS+ materials presumably representing mucin-filled goblet cells 
were found eleven days subsequent to transplantation into Balb/c athymic mice. 
5.13.4.10 Conjunctival Restoration with Cultured Conjunctival Epithelial Cells
Cultured conjunctival epithelial cells have been used to repair conjunctival defects following 
pterygium surgery (Fig. 17) (Tan et al., 2004; Ang et al., 2005), removal of conjunctival nevus 
(Fig. 18) (Tan et al., 2004) and recurrent viral papillomata (Fig. 19) (Ang and Tan, 2005), 
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leaking trabeculectomy blebs (Tan et al., 2004) and bilateral superior limbic 
keratoconjunctivitis (Tan et al., 2004). Sangwan and co-workers reported a technique 
combining the culture of limbal and conjunctival epithelial cells for the treatment of LSCD 
and symblepharon due to chemical burns (Sangwan et al., 2003a).
Figure 17. Transplantation of cultured human conjunctival epithelial (HCjE) cells for the 
treatment of pterygium. Photographs showing pre- (A) and post- (B) transplantation of 
cultured HCjE cells. Adapted from Tan et al. 2004. 
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Figure 18. Transplantation of cultured human conjunctival epithelial (HCjE) cells for the 
treatment of an extensive nevus. Photographs showing pre- (A and B) and post- (C and D) 
transplantation of cultured HCjE cells. Adapted from Tan et al. 2004. 
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Figure 19. Transplantation of cultured human conjunctival epithelial cells for the treatment of 
a recurrent viral papilloma. Photographs showing pre- (A and B) and post- (C and D) 
transplantation of cultured human conjunctival epithelial cells. Adapted from Ang and Tan 
2005. 
5.13.5 Tissue Engineered Conjunctival Substitutes with Non-conjunctival 
Epithelial Cells
Epidermal epithelial cells cultured on AM have been transplanted to Rhesus monkeys to 
replace damaged conjunctiva (Lu et al., 2011). A multilayered, viable transplant was still 
present two weeks after the transplantation. The presence of conjunctival markers in the 
transplant, including MUC4 and CK4, was confirmed with immunohistochemistry (IHC). 
Goblet cells, however, were not detected.
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5.13.6 Corneal Restoration with Cultured Conjunctival Epithelial Cells
Transplantation of cultured conjunctival epithelial cells has been used to treat contact lens-
related corneal abnormalities in humans (Clinch et al., 1992) and LSCD in rabbits (Tanioka et 
al., 2006; Ono et al., 2007; Ang et al., 2010) and humans (Fig. 20) (Di Girolamo et al., 2009; 
Ricardo et al., 2012).
Figure 20. Transplantation of cultured conjunctival epithelial cells for the treatment of limbal 
stem cell deficiency (LSCD). (A) Prior to surgery. (B) Twelve months post-surgery. Adapted 
from Ricardo et al. 2012. 
5.13.7 Eyelid Reconstruction
The eyelid can be divided into an anterior and posterior lamella, where the former consists of 
the skin and orbicularis muscle and the latter the tarsus and conjunctiva (Schrader et al., 
2009b). In cases with a full thickness eyelid defect exceeding 25% of the width of the lid the 
superior and inferior lids cannot be closed directly. In such cases the patient needs a full 
thickness graft (Spinelli and Jelks, 1993).
5.14 Storage
One of the main benefits of storing cells is to create a logistical window in which one can plan 
further use of the cells. The longer the cells can be stored while maintaining quality and the 
less preparation needed after storage before the cells can be used, the longer this time window 
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becomes. Cell suspensions can be cryopreserved for long periods, but the cells usually must 
be expanded ex vivo before transplantation as well as cultured to form the organized tissue it 
is replacing (exceptions include injections of cells into the patient’s eye as a cell suspension, 
e.g. RPE cells (Durlu and Tamai, 1997)). Storage of organized cells or tissues, on the other 
hand, has the benefit of being instantly transplantable upon end of storage. Hence, the benefit 
of storing “ready-to-use” tissues it that it can be shipped on very short notice from culture 
laboratories to transplantation clinics, which do not need cell culture facilities or expertise. 
Moreover, it does not necessitate the use of nitrogen freezer.
5.14.1 Whole Cornea Storage
Corneas have been and are still being, stored differently throughout the world. For same-day 
corneal transplantations enucleated eyes can be kept in moist chambers (Ehlers et al., 2009). 
For longer duration storage there are three current approaches: cold storage, cryopreservation 
and organ culture. Corneal cold storage at 4℃, first introduced in 1974 (McCarey and 
Kaufman) employs the Optisol-GS medium which consists of a traditional culture medium 
(TC-199) supplemented with antibiotics, dextran (anti-swelling) and antioxidants. Using cold-
storage, corneas can be preserved for maximally ten days (Ehlers et al., 2009). Different 
cryopreservation techniques have been explored, with (Capella et al., 1965) or without 
crystallization (vitrification) (Rich and Armitage, 1992); or the inclusion of an additional 
processing step with organ culture (Ehlers et al., 1982; Erdmann and Ehlers, 1993). The poor 
ability to preserve the corneal endothelium and the complex technique of cryopreserving 
corneas have prevented this method from being widely used, however (Armitage, 2009). 
Using the organ culture technique (Summerlin et al., 1973; Bourne et al., 1977) the corneas 
are maintained in a closed bottle at 31℃ in a basal medium supplemented with FBS for two 
to four or seven weeks, if the medium is changed (Ehlers et al., 1999; Ehlers et al., 2009). 
Among the benefits with organ culture preservation are the possibility for longer preservation 
and the feasibility of sterility control prior to surgery (Ehlers et al., 2009), which decreases the 
chance of primary graft failure (Ehlers et al., 2009). The technique of organ culture storage 
has also been investigated for conjunctival tissue (Berry and Radburn-Smith, 2005). 
 In addition to the storage method, the age of the donor and the death-to-preservation 
interval (DPI) may affect the quality of the corneas (Kryczka et al., 2011). It is generally 
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suggested that the corneas should be harvested as soon as possible after death (Slettedal et al., 
2008). Cold-storage, however, can potentially minimize the adverse metabolic effects on the 
cornea due to a long DPI (Kryczka et al., 2011).
5.14.2 Above Zero Degree Storage of Cultured Ocular Surface Cells
The rational for storing cells and tissues above freezing point is to avoid cryopreservation-
associated cell damage. Nevertheless, some degree of temperature reduction is usually 
involved during storage to protect the cells against degradation (Rauen and de Groot, 2002). 
Storing cells at temperatures below 37°C reduces their metabolism by slowing down the rate 
of enzymatic reactions (Rauen and de Groot, 2002). Although this may preserve the stored 
tissue, by decreasing the rate of injurious cell processes, temperatures that are too cold (e.g. 
0°C to 10°C) can conversely have a detrimental effect on cell viability owing to electrolyte 
disturbances and oxidative stress (Rauen and de Groot, 2002).
5.14.2.1 Adherent Cell Cultures
To our knowledge, only one study has demonstrated successful above zero degree storage of 
cultured HCjE cells (Eidet et al., 2012b). Scuderi and co-workers, however, described a few 
hours storage of cultured HCjE cells prior to transplantation, though they did not report the 
tissue viability prior to transplantation (Scuderi et al., 2002). Our group have showed the 
feasibility of storing cultured HLEC on AM at 23℃ in minimum essential medium (MEM), 
which was buffered with 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) and 
supplemented with FBS, for one week (Utheim et al., 2007). Storage at 23℃ yielded higher 
viability and better morphology than storage in Optisol-GS at 5℃ and in organ culture at 
31℃ degrees, while maintaining phenotype of the stored cells (Raeder et al., 2007b). Using a 
structurally modified calcium alginate hydrogel as substrate instead of AM, Wright et al. also 
demonstrated the possibility of storing cultured limbal epithelial cells (LEC) at ambient 
temperature (2012). Epidermal cells are considered a potential cell source for treating ocular 
surface disorders, such as LSCD. Storage of cultured epidermal epithelial cells for up to 20 
days showed superior results at 22-24℃ compared to storage at 4℃ and 37℃ (Bolivar-Flores 
et al., 1990), which supports our groups previous studies on cultured HLEC.
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5.14.3 Below Zero Degree Storage - Cryopreservation
5.14.3.1 Cell Suspensions
Cell suspensions have traditionally been cryopreserved, which is the most widely used cell 
storage method. There are two principal mechanisms of cell injury during freezing cell 
suspensions: 1) intracellular ice-formation and 2) solution effects (Mazur, 1970, 1984; 
Armitage, 2009). The extent to which cells are damaged by any of these processes depends on 
the cooling rate (Mazur, 1970, 1984). The formation of extracellular ice crystals removes pure 
water but leaves the solutes, thereby exposing the cells to a hyperosmolar extracellular fluid. 
This, however, causes osmotic efflux of intracellular water, thereby shrinking the cells 
preventing intracellular ice formation. Higher cooling rates, on the other hand, lead to 
intracellular ice formation as the intracellular water freeze before it leaves the cells. In 
addition, the rate of warming the cells will affect the cell viability (Miller and Mazur, 1976). 
Cryopreserved conjunctival epithelial cell suspensions demonstrated comparable CFE and 
number of cell doublings as cells that were not cryopreserved (Schrader et al., 2009a).
5.14.3.2 Tissues
Tissues, including cell sheets, are usually more susceptible to cryopreservation damage than 
cell suspension (Armitage, 2009). This is due to factors including the presence of a higher cell 
concentration and intercellular junctions, which may promote spreading of intracellular ice to 
neighboring cells (Taylor and Pegg, 1983; Berger and Uhrik, 1996; Acker et al., 2001). As 
cryopreserved cell sheets are especially vulnerable to intracellular ice-formation it is essential 
to avoid too rapid cooling-rates (Routledge and Armitage, 2003). Some studies, however, 
have reported high viability after cryopreservation of monolayer cultures of conjunctival 
epithelial cells (Zheng et al., 2000; Oh et al., 2007). Oh and co-workers cultured rabbit 
conjunctival epithelial cells and demonstrated 95% viability after one-week cryopreservation 
of the cell sheets (2007). The conjunctival cells were stored in a medium containing 50% FBS 
and the cultures were co-cultured with 3T3 fibroblasts. Zheng and co-workers did not 
describe the storage medium used. They reported resuscitation of 90% of the cultured HCjE 
cells after 30 days of cryopreservation. Only one study has mentioned successful 
cryopreservation of stratified HCjE cultures (Scuderi et al., 2002), however, they did not 
report the percentage of viable cells upon thawing nor what storage medium they used or how 
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long they preserved the cells. Cryopreservation of stratified cultures with cultured LEC has 
demonstrated far lower viability (Kito et al., 2005; Yeh et al., 2008). 
5.14.3.3 Vitrification
Vitrification is essentially freezing without ice-formation, a technique through which the 
cryopreservation-associated cell injuries mentioned above potentially could be avoided 
(Armitage, 2009). This technique necessitates an extremely high solution viscosity to inhibit 
the formation of ice crystals, in addition to a more rapid cooling rate (Armitage, 2009). 
Disadvantages of vitrification include the need for very high concentrations of cryoprotectants 
and that the method is exceedingly complex and time consuming (Armitage, 2009).
5.14.4 Hibernation
In contrast to simple lowering of the ambient temperature to extend cell survival, hibernation 
represents an innate mechanism to ensure long-term survival in a hypometabolic state (Storey, 
2010). Through hibernation the cell induces global metabolic depression (Storey and Storey, 
2004, 2007) and suppresses transcription/translation (Frerichs et al., 1998; Osborne et al., 
2004), while at the same time critical genes are upregulated and access to DNA transcription 
are moderated by histones (Morin and Storey, 2006). Other key preserving factors during 
hibernation are antioxidant defense (Buzadzic et al., 1990; Drew et al., 2002; Carey et al., 
2003; Tan et al., 2005; Ohta et al., 2006; Okamoto et al., 2006; Morin and Storey, 2007; 
Morin et al., 2008), chaperones, the unfolded protein response (Schroder, 2008) and the 
inhibition of inflammation by serpins (Gettins, 2002). If hibernation could be induced in cells 
before storage several of the harmful effects of exposing the tissue to cold-temperature during 
storage could possibly be avoided (Storey, 2010). Indeed, reversible hibernation has been 
pharmacologically induced in HeLa cells (Vecchio et al., 2006). Hence, understanding and 
implementing techniques for cell hibernation during storage of tissue-engineered substitutes 
may have great potential.
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5.15 Unresolved Issues with Current Methods of Ex Vivo 
Expansion of Conjunctival Epithelial Cells
5.15.1 Site of Biopsy Harvesting
In order for a conjunctival substitute to be successful, it must contain goblet cells (Schrader et 
al., 2009b; Mason et al., 2011). Despite the importance of goblet cells in conjunctival 
regeneration, the impact on the cultured transplant of harvesting conjunctival tissue from 
different regions has never been investigated. In the human fetus goblet cells first appear in 
the fornix and then move towards the tarsal and bulbar regions at nine weeks (Miyashita et al., 
1992). Goblet cells are located at the highest density in the forniceal conjunctiva in mice 
(Lavker et al., 1998; Nagasaki and Zhao, 2005), rats (Setzer et al., 1987; Yamabayashi and 
Tsukahara, 1987; Huang et al., 1988), canines (Moore et al., 1987; Goller and Weyrauch, 
1993), domestic ruminants (Weyrauch, 1983b) and humans (Vujkovic et al., 2002). Like 
intestinal and respiratory epithelial stem cells, conjunctival stem cells are capable of 
committing to both non-goblet and goblet cell lineage (Bjerknes and Cheng, 1981; McDowell 
et al., 1987; Pellegrini et al., 1999). The location of the conjunctival stem cells has been a 
matter of some controversy. Conjunctival stem cells have been reported to reside in the 
limbus (rat (Pe'er et al., 1996)), forniceal conjunctiva (rabbit (Wei et al., 1993)), mouse 
(Lavker et al., 1998)), palpebral conjunctiva (rat (Chen et al., 2003)) and mucocutaneous 
junction (rat (Pe'er et al., 1996)) and rabbit (Wirtschafter et al., 1999)). Nagasaki et al. (2005) 
reported that mice bulbar conjunctival cells were capable of self-renewal in situ and 
concluded that conjunctival stem cells are evenly distributed in bulbar conjunctiva. Others 
have suggested that pockets of conjunctival stem cells reside throughout the bulbar 
conjunctiva (Qi et al., 2010). These studies support the findings of Pellegrini et al. (1999), 
who proposed that the conjunctival stem cells are evenly distributed in human bulbar and 
forniceal conjunctiva. Few studies have used tissue harvested from different conjunctival 
regions when culturing goblet cells (Nizam et al., 2008) and no studies have determined the 
optimal harvesting site for culturing goblet cells.
5.15.2 Conjunctival Epithelial Cell Storage
Storage of cultured HCjE cells for some days, preferably a week, have several advantages: 
Firstly, storage in a closed container with a septum renders microbiological testing and quality 
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control possible, both of which will be increasingly more important due to increasingly 
stricter EU directives. Secondly, storage enables transportation, making the products available 
worldwide. Thirdly, the possibility of preserving the cells makes large-scale production in 
centralized and highly specialized centers attractive. Finally, the method alleviates the 
logistical challenges by giving both the patient and surgeon an open interval for the operation 
to take place (Raeder et al., 2007b; Utheim et al., 2007). We have previously shown that 
cultured HLEC can be successfully stored at 23°C for one week (Raeder et al., 2007b; Utheim 
et al., 2007). If cultured conjunctival epithelial cells also may be stored under similar 
conditions this will increase the accessibility to treatment for not only corneal surface 
diseases, but to diseases affecting the entire ocular surface and eye lids.
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6. AIMS OF THE PRESENT STUDY
6.1 Overall Aims of the Study 
The primary overall objectives of the study were to (1) improve the method for ex vivo 
expansion of conjunctival epithelial cells and (2) improve the storage method for conjunctival 
explant cultures. 
6.2 Aims of the Individual Studies
Study I To evaluate the effect of location and size of biopsy on phenotype and 
proliferative capacity of cultured rat conjunctival epithelial cells.
Study II To investigate if the number of goblet cells ex vivo is affected by the biopsy 
harvesting site and distance from the explant.
Study III To investigate the feasibility of storing cultured HCjE cells in HEPES-MEM 
and Optisol-GS at 23°C for four and seven days.
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7. MATERIALS AND METHODS
7.1 Conjunctival Epithelial Cultures
7.1.1 Paper I and II - Conjunctival Explant Cultures on Glass Coverslips 
and Tissue Culture Plates
Male Sprague-Dawley rats were used as previously described (Shatos et al., 2001). 
Conjunctival tissue was excised at the 12 and 6 o’clock positions and immediately placed into 
phosphate-buffered saline (PBS; 145 milliMolar (mM) sodium chloride (NaCl), 7.3 mM 
sodium phosphate dibasic (Na2HPO4), 2.7 mM monosodium phosphate (NaH2PO4) [pH 7.2]). 
Tissue from each eye was divided into six pieces, superior and inferior bulbus, fornix and 
tarsus. The fornix was identified as the band running along the most posterior part of the fold 
at the junction of the bulbar and tarsal conjunctiva. The superior fornix was grasped and lifted 
and then excised from the conjunctiva. Thereafter, the superior tarsal and bulbar tissue were 
collected in similar fashion. Finally, the inferior tissues were excised accordingly after first 
identifying the inferior fornix. A total of six pieces, each measuring about 1-2 mm × 4 mm, 
were collected from each rat. The tissue was further divided into 0.5-1 mm2 pieces that were 
anchored onto glass coverslips placed within six-well culture dishes. With a yield of six 
explants from each conjunctival region, a total of 36 explants were obtained from each 
animal. One explant was anchored in each tissue culture well. The culture dishes contained 
just enough medium to cover the bottom of the dish so that the tissue would receive nutrients 
through surface tension. The cell medium used to feed explants consisted exclusively of 
Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 10% heat-
inactivated FBS, 2 mM L-glutamine and 100 μg/ml penicillin/streptomycin. This medium was 
changed every two days and the cultures grown for eight days under routine culture 
conditions of 95% air - 5% CO2 at 37°C.
7.1.2 Paper III - Conjunctival Explant Cultures on Amniotic Membranes 
Human conjunctival tissues, which were harvested from the superior and inferior forniceal 
regions, were rinsed three times with Dulbecco's Modified Eagle Medium (DMEM) 
containing 50 μg/ml gentamycin and 1.25 μg/ml amphotericin B. The donor samples were 
then subdivided into 2 ⨉ 2 mm explants under a dissecting microscope. Human AM was 
preserved as previously reported (Lee and Tseng, 1997), with some modifications. 
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Specifically, following caesarean section, the fetal membranes with placenta were transferred 
into 500 milliliter (mL) of transport medium (pH 7.4) consisting of sterile washing buffer 
(0.14 Molar (M) NaCl, 0.004 M potassium chloride (KCl), 0.001 M trisodium phosphate 
(TSP) and 0.01 M glucose), 50 U/mL penicillin (Sigma-Aldrich), 50 µg/mL streptomycin 
(Sigma-Aldrich) and 2.5 µg/mL amphotericin B (Sigma-Aldrich). The fetal membranes were 
separated from the placenta using scissors, washed in sterile washing buffer with added 
antibiotics and cleansed of blood clots. The AM with chorion was stretched out on 
nitrocellulose paper (0.45 µm pore size, OneMed, Vantaa, Finland) and the chorion was 
removed using forceps, leaving only the AM attached to the nitrocellulose paper. AM was 
stored in sterile cryo-tubes (Nunc, Roskilde, Denmark) at –70°C in a 1:1 (vol/vol) mixture of 
DMEM and glycerol (Sigma-Aldrich). Prior to use, the AM was thawed and washed three 
times with sterile PBS (Sigma-Aldrich). AM with the BM facing up was fastened to the 
polyester membrane of Costar Netwells (24 mm diameter, 74 µm pore size, Costar Corning, 
Corning, NY) using Ethicon Ethilon 6-0 monofilament sutures. Conjunctival explant cultures 
were prepared by placing the explants on the centre of each AM insert in a supplemented 
hormonal epithelial medium made of DMEM/Ham’s F12 (1:1) containing HEPES and sodium 
bicarbonate (Sigma-Aldrich). The medium was supplemented with 5% FBS (Sigma-Aldrich), 
0.5% dimethyl sulfoxide (Sigma-Aldrich), 2 ng/mL human epidermal growth factor (EGF) 
(Sigma-Aldrich), 5 µg/mL insulin (Sigma-Aldrich), 5 µg/mL transferrin (Sigma-Aldrich), 5 
ng/mL selenium (Sigma-Aldrich), 3 ng/mL hydrocortisone (Sigma-Aldrich), 30 ng/mL 
cholera toxin (Biomol, Exeter, UK), 50 µg/mL gentamycin and 1.25 µg/mL amphotericin B. 
Cultures were incubated for two weeks in a Heraeus HERAcell 240 l CO2 copper incubator 
(former Kendro Laboratory Products, Newtown, CT) at 37ºC in an atmosphere of humidified 
5% CO2 and 95% air and the medium was changed every two to three days. 
7.2 Storage of Cultured Conjunctival Epithelial Cells 
7.2.1 Paper III
Cultured HCjE cells were prepared for storage as previously reported with some 
modifications (Utheim et al., 2007). The polyester mesh membrane with the cultured 
epithelium attached was released using a steel blade. Unlike in previous experiments from our 
group where the grafts were transferred to an air- and watertight container, the cultured HCjE 
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cells were transferred to a secondary six-well culture plate for storage at 23°C. The HCjE 
cells were stored for four and seven days in 5 mL serum-free medium containing either MEM 
with 12.5 mM HEPES, 7.5% sodium bicarbonate, 50 µg/ml gentamycin, 100 µg/ml 
vancomycin (Abbott Laboratories, Abbott Park, IL) and 2.5 µg/ml amphotericin B; or 
Optisol-GS (Bausch & Lomb, Irvine, CA). 
7.3 Transmission Electron Microscopy
7.3.1 Paper III
Human conjunctival epithelial cells cultured for two weeks without subsequent storage 
(control; n = 3), with subsequent four days of storage (HEPES-MEM; n = 4 or Optisol-GS; n 
= 4) or seven days of storage (HEPES-MEM; n = 5 or Optisol-GS; n = 4) were processed for 
TEM analysis as previously described (Raeder et al., 2007a). In brief, ultrathin sections 
(60-70 nm thick) were cut on a Leica Ultracut Ultramicrotome (Leica, Wetzlar, Germany) and 
examined using a CM120 transmission electron microscope (Philips, Amsterdam, the 
Netherlands). The average number of microvilli/mm of epithelial length (Koufakis et al., 
2006) was measured using ImageJ software (Ver1.44 m). The number of cell layers was 
counted by two independent investigators.
7.4 Histology and Immunostaining 
7.4.1 Paper I and II
7.4.1.1 Histochemistry and Immunohistochemistry
Sections were deparaffinized, rehydrated and subjected to antigen retrieval before 
histochemistry and IHC. The antigen retrieval step was added as formaldehyde fixation is 
known to mask antigens due to cross-linking of proteins (Abcam). Antigen retrieval was 
performed by exposing the sections to 95-100°C for 20 minutes submersed in a buffer 
solution consisting of 10 mM tris(hydroxymethyl)aminomethane (Tris), 1 mM 
ethylenediaminetetraacetic acid (EDTA) and 0.05% Tween-20.
 Sections were incubated in blocking buffer, to decrease unspecific staining, for one 
hour at room temperature. For lectin histochemistry, this was followed by incubation for one 
hour at room temperature with UEA-1 lectin (Vector Laboratories, Burlingame, CA), a 
marker for goblet cell selective high molecular weight glycoconjugates, conjugated directly to 
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fluorescein isothiocyanate (FITC) diluted 1:3000 in PBS. Cells were incubated overnight at 
4°C with antibodies for markers of goblet cells and non-goblet ocular surface epithelial cells: 
CK7 (RCK105) (Santa Cruz Biotechnology), which recognizes a goblet cell–specific keratin 
(Kasper, 1991) (1:200); MUC5AC (45M1) (Thermo Fischer Scientific, Fremont, CA), 
specific for mucin produced by goblet cells (Argueso and Gipson, 2001) (1:100); CK4 (6B10) 
(Abcam Inc., Cambridge, MA), specific for stratified, squamous, non-goblet epithelial cells 
(Kasper, 1991) (1:200); ABCG2 (M-70) (Santa Cruz Biotechnology, Santa Cruz, CA), a 
putative stem cell marker (Budak et al., 2005) (1:200); and Proliferating cell nuclear antigen 
(PCNA) (FL-261) (Santa Cruz Biotechnology), a marker for proliferative capacity (Hall et al., 
1990) (1:200). The anti-mouse or anti-rabbit immunoglobulin G (IgG) secondary antibodies 
(Jackson Immuno Research Laboratories, Inc., West Grove, PA), conjugated to either cyanine 
dye 2 (Cy2) or cyanine dye 3 (Cy3), were diluted 1:100 and 1:300, respectively, in PBS and 
incubated for one hour at room temperature. Slides were washed three times in PBS, after 
which coverslips were mounted on the slides with mounting media containing 100 mM Tris 
(pH 8.5), 25% glycerol, 10% polyvinyl alcohol, 2.5% 1,4-diazobicyclo-[2.2.2]-octane and 4',
6-diamidino-2-phenylindole (DAPI).
 Sections adherent to microscope slides were visualized with an epifluorescence 
microscope (Eclipse E 800; Nikon, Tokyo, Japan) or laser confocal microscopy (Leica TCS-
SP5; Leica Microsystems, Wetzlar, Germany). Negative controls consisted of substituting 
PBS for the primary antibody. Positive controls included fixed sections of whole rat eyes with 
eyelids containing structures with known positive staining for each of the antibodies used. 
Semi-quantitative immunohistochemical analysis of the sections was carried out at a 
magnification of ⨉630 and scored as previously described (Eidet et al., 2012b). Positive 
staining in the sections was graded as 0 (undetectable), + (detectable in <¼ of the cells), ++ 
(detectable in ¼-½ of the cells), +++ (detectable in ½-¾ of the cells) and ++++ (detectable in 
>¾ of the cells).
7.4.1.2 Cytochemistry and Immunocytochemistry
Explant cultures on coverslips were methanol-fixed for 15 minutes, rinsed in PBS and then 
incubated for one hour at room temperature in blocking buffer that consisted of 1% bovine 
serum albumin (BSA) and 0.2% Triton X-100 in PBS. Cells were then incubated overnight at 
4°C with the following dilutions of primary antibodies in PBS: Antibody to p63 (1:100), a 
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marker for undifferentiated and highly proliferative cells (Hsueh et al., 2004); anti-ABCG2 
(1:200) (M-70; Santa Cruz Biotechnology, Santa Cruz, CA); anti-PCNA (1:200) (FL-261; 
Santa Cruz Biotechnology); antibody against CK7 (1:200; RCK105; Santa Cruz 
Biotechnology); MUC5AC (1:100) (45M1; Thermo Fischer Scientific, Fremont, CA); UEA-1 
conjugated directly to FITC was diluted 1:1000 in PBS; and CK4 (1:200) (6B10; Abcam Inc., 
Cambridge, MA). The secondary antibodies, conjugated to either Cy2-or 3, were diluted 
1:100 or 1:300, respectively, in PBS and incubated for one hour at room temperature. 
Coverslips were washed three times in PBS, after which coverslips were mounted on 
microscope slides with mounting media containing 100 mM Tris (pH 8.5), 25% glycerol, 10% 
polyvinyl alcohol and 2.5% 1,4-diazobicyclo-[2.2.2]-octane. Cell cultures adherent to glass 
coverslips were visualized with an epifluorescence microscope (Eclipse E 800; Nikon). 
Negative controls consisted of substituting PBS for the primary antibody. Positive controls 
included fixed sections of whole rat eyes with eyelids containing structures with known 
positive staining for each of the antibodies used. Expression of the markers was assessed at a 
magnification of ⨉630 and 100 cells in six fields were counted in each culture by two 
independent investigators. The number of positive cells/total number of cells ⨉ 100% was 
calculated. 
7.4.2 Paper III
7.4.2.1 Histochemistry and Immunohistochemistry
The cultures were fixed in neutral buffered 4% formaldehyde and embedded in paraffin. 
Haematoxylin and eosin staining and IHC with a panel of proposed conjunctival stem cell, 
progenitor, differentiation, proliferation and apoptosis markers was performed on serial 
sections of 4.5 µm using Benchmark XT Antibody diluent (251-018) and Detection Kit 
Ventana ultraView Universal DAB (760-500), an automated immunostaining system based on 
the avidin-biotin-peroxidase complex (ABC) method, with negative and positive controls 
(Ventana Medical Systems, Inc., Tucson, AZ, USA). The immunoreactivity was graded as 0 
(undetectable), + (detectable positivity in <¼ of the cells), ++ (detectable positivity in ¼-½ of 
the cells), +++ (detectable positivity in ½-¾ of the cells) and ++++ (detectable positivity in 
>¾ of the cells). All scores were assigned at a magnification of ⨉630 by two independent, 
experienced investigators blinded to the origin of the samples.
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7.5 Cell Viability Assays
7.5.1 Paper III
Viability staining was performed using a calcein-acetoxymethyl ester (CAM)/ethidium 
homodimer 1 (EH-1) (Invitrogen, Carlsbad, California) assay as described previously by the 
group (Fig. 21) (Utheim et al., 2009b). In brief, HCjE cells cultured for two weeks but not 
stored (n = 7), stored for four days in HEPES-MEM (n = 7) and Optisol-GS (n = 8) and stored 
for seven days in HEPES-MEM (n = 4) and Optisol-GS (n = 5) were incubated in PBS 
containing 2 mM CAM and 2 mM EH-1 for 45 min at 23°C, then rinsed with PBS. Epithelial 
discs were trephined using a 6 mm Kai biopsy punch (Kai Industries, Gifu, Japan) and 
mounted on coverslip glass slides. Fluorescence images of the basal layer were recorded using 
an Axiovert 100 LSM 510 laser scanning confocal microscope (Carl Zeiss Microscopy, 
Oberkochen, Germany). The number of live and dead cells (green and red fluorescence, 
respectively) was counted in five fields at a magnification of ⨉250 and the percentage of live 
cells calculated. Human conjunctival epithelial cells cultured for two weeks and then exposed 
to methanol for 1 hour (n = 2) were used as positive controls for dead cells.
Figure 21. Epifluorescence microscopy photomicrographs showing that live conjunctival 
epithelial cells (A) were generally calcein-acetoxymethyl ester (CAM) positive (green) and 
ethidium homodimer-1 (EH-1) negative (red), while methanol-fixed dead cells (B) were EH-1 
positive and CAM negative. Original magnification: ⨉40.
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7.6 Colony-forming Efficiency Assay
7.6.1 Paper I
The clonal growth capacity of epithelial cells from the superior and inferior bulbar, forniceal 
and tarsal membrane of the conjunctiva was determined by a CFE assay (n = 9). Conjunctival 
tissues from six regions were left in Dispase II overnight at 4°C, thereafter trypsinized for ten 
minutes at 37°C to achieve single cells. Mitomycin C treated 3T3 feeder cells were seeded 
onto six- and 12-well plates at a density of 1 ⨉ 105/cm2 24 hours before plating conjunctival 
cells at a clonal density of 50 cells/cm2. A colony was defined as a group of eight or more 
contiguous cells (Fig. 22) (Nakamura et al., 2006a). Colonies were fixed on day eight, stained 
with Rhodamine B Fluka (ready to use solution, Sigma) and counted independently by two 
investigators; data were then averaged. Colony-forming efficiency was defined as follows: 
CFE (%) = total number of colonies formed at the end of growth period/total number of cells 
seeded ⨉ 100%.
Figure 22. Colony-forming efficiency (CFE) assay. Phase contrast photomicrographs 
showing two circular conjunctival epithelial cell cultures before (A) and after (B) staining 
with Rhodamine B Fluka (red). The CFE assay in paper I was performed by counting the 
number of colonies using an inverted phase contrast microscope. Eight or more contiguous 
cells were defined as a colony. Original magnification: ⨉40.
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7.7 Outgrowth Measurements
7.7.1 Paper I and II
The degree to which the cells grow out from the explant can be used as a measure of 
proliferative and migratory capacity (Fig. 23). In paper I and II we measured the outgrowth in 
primary culture to assess the proliferative capacity of different harvesting sites in the 
conjunctiva and to investigate the effect of distance to the explant on phenotype. 
Figure 23. Photomicrographs of the same conjunctival explant culture captured at 
consecutive time points showing how the conjunctival epithelial cells grow out from the 
explant. Original magnification: ⨉100.
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 Nuclei of epithelial cells in primary culture grown from explants from the superior and 
inferior bulbar, forniceal and tarsal areas of the conjunctiva were stained with DAPI and 
outgrowth was visualized with a fluorescence microscope (Eclipse E800; Nikon) at a 
magnification of ⨉40 (n = 6). Occasional areas with fibroblasts were recognized by 
morphology and excluded (Fig. 24). After eight days in culture outgrowth size and explant 
size were quantified using ImageJ software (National Institute of Health, Bethesda, MD). 
Fold growth in each primary culture was quantified as follows: outgrowth size/explant size.
F i g u re 2 4 . P h o t o m i c ro g r a p h 
displaying a rat conjunctival epithelial 
e x p l a n t c u l t u r e e x t e n s i v e l y 
contaminated with conjunctival 
fibroblasts (A). An explant culture 
without fibroblast contamination is 
shown in comparison (B). * Explant 
area. ** Epithelial outgrowth. *** 
Fibroblast contamination identified by 
their elongated nuclei and wavy 
growth pattern. Cell nuclei were 
s tained with 4 ' ,6-diamidino-2-
phenylindole (DAPI). Red dotted line: 
Explant demarkation line. Yellow 
dotted line: Border between epithelial 
cells and fibroblasts. Original 
magnification: ⨉40.
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7.8 Statistical Analysis 
7.8.1 Paper I
The Mann–Whitney test was used to compare measurements of fold growth between all six 
conjunctival regions. In contrast to these measurements, all the CFE measurements were 
paired, hence the Wilcoxon test was used for comparison of CFE between the six conjunctival 
regions. To analyze the relationship between fold growth, outgrowth size and explant size, as 
well as between outgrowth size, explant size and phenotypic data, the Spearman’s rank order 
correlation test was used. Data were expressed as mean ± standard error of the mean (SEM). 
A significance level of P < 0.05 was used throughout the study (Statistical Package for the 
Social Sciences (SPSS) ver. 18.0).
7.8.2 Paper II
The Mann–Whitney test was used to compare phenotypic data between all six conjunctival 
regions as well as between cells near the explant and close to the leading edge. To analyze the 
relationship between outgrowth size and phenotypic data, the Spearman’s rank-order 
correlation test was used. Spearman’s rank-order correlation test and a paired sample T-test 
were employed to assess observer agreement. Data were expressed as mean ± SEM. A 
significance level of P < 0.05 was used throughout the study (SPSS ver. 18.0).
 
7.8.3 Paper III
Data were presented as mean ± standard deviation (SD). To assess the difference between the 
groups, a one-way analysis of variance (ANOVA), followed by Tukey’s test to control for 
multiple comparisons were performed. A significance level of P < 0.05 was used throughout 
the study (SPSS ver.18.0).
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8. SUMMARY OF RESULTS
8.1 Paper I
Paper I evaluated the effect of location and size of biopsy on phenotype and proliferative 
capacity of cultured rat conjunctival epithelial cells. Epithelial cells from six regions of rat 
conjunctiva were grown in RPMI 1640 with 10% FBS for eight days. Analysis included 
immunocytochemistry (ICC), outgrowth measurements and a CFE assay. Superior (23.9 ± 2.9 
fold growth) and inferior (22.4 ± 1.2 fold growth) forniceal tissues yielded significantly more 
outgrowth with respect to explant size than superior bulbar (13.4 ± 1.9 fold growth; P < 0.05 
and P < 0.01, respectively), inferior bulbar (13.6 ± 1.6 fold growth; P = 0.01 and P < 0.01, 
respectively) and inferior tarsal tissues (14.0 ± 1.3 fold growth; P = 0.01). Outgrowth size 
correlated positively with explant size (Spearman's rank correlation coefficient/rho (rs) = 0.54; 
P < 0.001), whereas explant size correlated negatively with fold growth (rs = 0.36; P < 0.001). 
Superior forniceal cells displayed higher CFE (3.6% ± 0.9%) than superior bulbar (1.1% ± 
0.3%; P < 0.05) and inferior bulbar cells (1.6% ± 0.8%; P < 0.05). Percentage of p63+ and 
PCNA+ cells correlated positively with explant and outgrowth size. Small forniceal 
conjunctival explants grow the most effectively. However, for transplantation purposes the 
loss of p63+ and PCNA+ cells with small explants must be considered.
8.2 Paper II
In paper II we investigated if the number of goblet cells ex vivo is affected by the biopsy 
harvesting site and distance from the explant. Sections of whole rat conjunctiva were 
processed for IHC. Explants from six regions of rat conjunctiva were grown in RPMI 1640 
with 10% FBS on coverslips for eight days and the cultures were processed for ICC and 
outgrowth measurements with ImageJ. In the conjunctival sections all three goblet cell 
markers showed fewest goblet cells in the superior bulbar region, followed by the inferior 
bulbus, while the highest concentrations were found in the forniceal and tarsal regions. 
Distribution of the CK4+ stratified, squamous non-goblet epithelial cells was mainly opposite 
that of the goblet cells, with higher concentrations in the bulbar regions than in the forniceal 
regions. Cultures from superior and inferior fornix contained the most goblet cells, with 
60.8% ± 9.2% and 64.7% ± 6.7% being CK7+, respectively, compared to the superior tarsal 
(26.6% ± 8.4%; P < 0.05), superior bulbar (31.0% ± 4.0%; P < 0.05), inferior bulbar (38.5% ± 
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9.3%; P < 0.05) and inferior tarsal regions (27.7% ± 8.3%; P < 0.05). While 28.4% ± 6.3% of 
CK7+ goblet cells co-labeled with PCNA, only 7.4% ± 1.6% of UEA-1+ goblet cells did (P < 
0.01). The number of goblet- and non-goblet cells ex vivo was affected by distance from the 
explant and culture size. We conclude that ex vivo expansion of forniceal conjunctiva 
generates the highest number of goblet cells. CK7+/UEA-1- cells seem to have the highest 
proliferative potential for goblet cell transplantation.
8.3 Paper III
Paper III investigated the feasibility of storing HCjE cells in the serum-free media HEPES-
MEM and Optisol-GS at 23°C for four and seven days, respectively. The five experimental 
groups were analyzed by light microscopy, IHC, TEM and a viability assay. The 
ultrastructural integrity of cultured HCjE cells was well preserved following four days of 
storage, however, seven days of storage resulted in some loss of cell-cell contacts and 
epithelial detachment from the AM. The number of microvilli in cultured HCjE cells not 
subjected to storage was 2.03 ± 0.38 microvilli/μm. In comparison, after four and seven days 
of HEPES-MEM storage this number was 1.69 ± 0.54 microvilli/μm; P = 0.98 and 0.89 ± 1.0 
microvilli/μm; P = 0.28, respectively. After Optisol-GS storage for four and seven days, the 
mean number of microvilli was 1.07 ± 1.0 microvilli/μm; P = 0.47 and 0.07 ± 0.07 microvilli/
μm; P = 0.03, respectively. The number of cell layers in cultured HCjE cells not subjected to 
storage was 4.4 ± 0.3 cell layers, as opposed to 4.0 ± 0.9 cell layers; P = 0.89 after four days 
of HEPES-MEM storage and 2.8 ± 0.6 cell layers; P = 0.01 after seven days of storage in 
HEPES-MEM. The number of cell layers after four and seven days of storage in Optisol-GS 
was 3.7 ± 0.2 cell layers; P = 0.46 and 3.4 ± 0.4 cell layers; P = 0.18, respectively. The 
expression of markers for undifferentiated cells (ΔNp63α, ABCG2 and p63), proliferating 
cells (Ki67 and PCNA), goblet cells (CK7 and MUC5AC), stratified squamous epithelial cells 
(CK4) and apoptotic cells (caspase-3) in cultured HCjE cells appeared to be unchanged after 
four and seven days of HEPES-MEM and Optisol-GS storage. The percentage of viable cells 
in cultured HCjE cells not subjected to storage (91.4% ± 3.2%) was sustained after four and 
seven days of storage in HEPES-MEM (94.1% ± 4.5%; P = 0.99 and 85.1% ± 13.7%; P = 
0.87, respectively) as well as after four and seven days of storage in Optisol-GS (87.7% ± 
15.2%; P = 0.97 and 79.8% ± 15.7%; P = 0.48, respectively). We conclude that cultured HCjE 
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cells may be stored for at least four days in serum-free conditions at 23°C while maintaining 
the phenotype and viability. HEPES-MEM appears to be comparable to Optisol-GS for 
serum-free storage with preservation of the ultrastructure for at least four days.
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9. GENERAL DISCUSSION 
9.1 Methodological Considerations
9.1.1 Choice of Culture Method
The three papers employed two slightly different culture protocols; explants were cultured on 
either AM for two weeks or on glass coverslips for eight days. The culture media used 
included either DMEM/F12 or RPMI-1640, both supplemented with FBS.
 In paper I and II we built on the experience of the Dartt laboratory with their rat 
conjunctival primary culture protocol for generating goblet cells in vitro. Dartt and colleagues 
have demonstrated successful culturing of both rat (Shatos et al., 2001) and human (Shatos et 
al., 2003) goblet cells when culturing explants in vitro in RPMI 1640 supplemented with FBS.
In paper III we sought to develop a method for storing cultured HCjE cells for subsequent 
clinical use. We cultured the HCjE cells on AM since all previous studies demonstrating 
transplantation of cultured HCjE cells to restore the human conjunctiva (Tan et al., 2004; Ang 
and Tan, 2005; Ang et al., 2005) and cornea in LSCD (Ricardo et al., 2012), have used AM as 
culture substrate. As we aimed at developing the storage and not the culture method of HCjE 
cells, we did not culture the cells in an ACF medium. Although not a completely xenobiotic-
free culture medium, in Tan and Ang’s studies they used a serumfree medium, with the only 
animal compound being bovine pituitary extract (Tan et al., 2004; Ang and Tan, 2005; Ang et 
al., 2005). Ricardo et al. employed a culture medium much similar to the one utilized for 
paper III, although with a 10% instead of 5% concentration of FBS (Ricardo et al., 2012). 
 We consistently applied an explant culture protocol instead of cell suspension culture. 
There are several reasons for this. First, the use of explants in our studies is encouraged by 
previous successful clinical studies (Tan et al., 2004; Ang et al., 2005; Di Girolamo et al., 
2009; Ricardo et al., 2012). Second, there are qualitative differences between cell suspension 
culture and explant culture. Chen et al. (2011) demonstrated that complete removal of the 
ECM (e.g following dispase treatment), resulted in poorer outgrowth and clonal growth 
compared to the use of collagenase, in which case some ECM remains. Third, the use of cell 
suspension culture in vitro usually warrants a co-culture technique including feeder cells (Wei 
et al., 1993), thereby introducing another undefined factor (xenobiotic cells) in the culture 
protocol that may decrease the reliability of the results, transfer infectious agents, as well as 
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possibly causing subsequent immunorejection if the cells were transplanted (Martin et al., 
2005).
9.1.2 Storage Method
9.1.2.1 Storage Medium
The development of an ACF storage media is currently an area of immense interest not only 
within ophthalmology, but also within all fields of organ transplantations and regenerative 
medicine. At the present time, there is an unmet demand for ACF media and it is of high 
priority to avoid the use of animal compounds, such as FBS, because of multiple 
accompanying disadvantages when applied in a clinical setting. Such disadvantages include 
the risk of bovine spongiform encephalopathy and infection with animal viruses and 
bacteriophages (Geier et al., 1975; Kniazeff et al., 1975; Frueh and Bohnke, 2000); the risk of 
inducing subsequent immunorejection due to the introduction of animal proteins in the 
transplant (Martin et al., 2005); the risk of possible alterations in the components of FBS used 
(Engelmann et al., 1998); and finally, the possibility for high variability between the FBS 
batches renders the standardization of storage media and hence their validation by the health 
authorities, very difficult (Thuret et al., 2005). Due to these reasons, the HCjE cells in paper 
III were stored in a defined basal cell culture medium, MEM, without the addition of any 
animal compounds. The choice of this storage medium was partly based on our research 
group’s previous studies (unpublished) on HLEC showing superior cell preservation when 
using MEM without FBS compared to when including FBS.
9.1.2.2 Storage Temperature
We only employed above-zero degree temperatures for storage, thus we did not include 
cryopreservation. There are various reasons for the omission of cryopreservation studies. The 
most important one being our aim at improving short-term and not long-term, storage. The 
possibility of storing cultured cells for at least a few days (i.e. short-term storage) would be 
enough to ease logistical difficulties (O'Callaghan and Daniels, 2011) regarding 
transplantations and potentially improve outcomes by providing time for quality control of the 
transplant (Utheim et al., 2009b). Furthermore, short-term storage is sufficient to enable 
transportation of tissue (Ahmad et al., 2010), which will become increasingly important in 
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regenerative medicine as various technologies leave the experimental stage to be used in 
mainstream medicine. Whereas cryopreservation is the standard method for storing cells in 
suspension, cryopreservation of adherent stratified ocular epithelia has been less successful 
(Kito et al., 2005; Yeh et al., 2008). In addition, when only short-term storage is required, 
above-zero degree storage methods are more convenient than cryopreservation, which 
necessitates expensive cryopreservation facilities and expertise.
9.1.2.3 Storage Conditions
For the storage experiments in paper III, culture plates were stored in a commercial wine 
cooler set at 23°C. To be able to store the cells in regular air the storage medium contained 
HEPES, as the HCO3- buffer does not maintain physiological pH without CO2 incubation 
(Mackenzie et al., 1961; Itagaki and Kimura, 1974). The HEPES buffer is also ideal for 
hypothermic cell storage as it is effective over the entire 0°C to 40°C temperature range 
(Baicu and Taylor, 2002). As HEPES is known to be photo-toxic the stored cells were 
protected from light (Zigler et al., 1985; Lepe-Zuniga et al., 1987).
9.1.3 Analyses
In the three studies the cell morphology was assessed by bright-field light microscopy of 
H&E sections and TEM; protein expression was investigated by ICC/IHC; cell proliferation 
by cell outgrowth measurements and CFE assay; and viability by a CAM/EH-1 assay.
9.1.3.1 Light and Electron Microscopy
Morphology was subjectively assessed throughout the studies, mostly to assess cell health. 
Visual signs of cell damage depend on the magnifications used and properties of the tissue 
sample. On H&E-stained sections signs of cell damage range from cytosolic granulation, loss 
of cell attachment, cell fragmentation, nuclear halo/condensation/fragmentation and cellular 
edema.
 Electron microscopy, enabling the visualization of the ultrastructure of the cells, can 
reveal more detailed images of cell destruction not otherwise seen on lower magnification 
images. Signs of cell membrane damage, such as membrane discontinuities and membrane 
blebbing can easily be detected. Transmission electron microscopy gives detailed images of 
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both intra/extracellular changes, including loss of cell organelles, chromatin rearrangement 
and loss of hemidesmosomes and desmosomes. Based on morphology cell death can be 
characterized as apoptotic or necrotic or as a combination. In brief, apoptotic cell death 
conserves the organelles and cell membrane for some time whereas the nucleus undergoes 
early degeneration. In necrotic cell death, however, the nucleus stays relatively intact while 
the cell membrane and organelles show early degeneration (Vitale et al., 1993). Apoptotic 
cells typically first show signs of cap-shaped chromatin margination (Falcieri et al., 1994; 
Stuppia et al., 1996). Cytosol condensation, pyknosis and cell membrane blebbing may also 
be seen (Fig. 25). The nucleus then develops several electron dense micronuclei, which are 
often released to the extracellular space. Finally, the cells split into numerous apoptotic 
bodies. In vitro, however, the apoptotic cells undergo a late phase of necrosis. A key event in 
necrosis is early cell membrane damage (Buja et al., 1993; Ziegler and Groscurth, 2004). 
Pyknotic and fragmented cell nuclei are not common in necrosis, instead, the cells either show 
1) autophagic cell death characterized by numerous cytosol vacuoles filled with cellular 
remnants; or 2) a non-lysosomal cell death with swell and dilation of organelles (Clarke, 
1990; Ziegler and Groscurth, 2004).
Figure 25 . Transmiss ion 
electron photomicrograph of a 
human conjunctival epithelial 
cell with a condensed and 
pyknotic nucelus (Pk), thus 
showing signs of apoptosis. 
Original magnification: ⨉3400. 
Scale bar: 10µm.
104
9.1.3.2 Immuno- and Histochemical Stainings
Immunostaining methods are based on the specific binding of an antibody to the epitopes of 
the antigen (Janeway et al., 2001). The location of the antibody can then be detected by 
linking it, directly or indirectly, to fluorophores or enzymes that cleave a colorless chromogen 
into colored products. The protein expression in the three papers was visualized by IHC using 
immunofluorescence (paper I-II) and the ABC method (paper III) and the protein expression 
was quantified subjectively by blinded independent investigators. Prior to immunostaining the 
tissue samples were fixed with formalin/formaldehyde or methanol. For IHC, the fixed tissue 
samples were then embedded in paraffin and sectioned. Formalin-fixed paraffin-embedded 
samples enable superior morphology compared to frozen sections. Using the latter method the 
non-fixed samples are embedded in optimal cutting temperature compound (OCT), then 
frozen and sectioned. However, formalin is known to mask antigens due to cross-linking of 
proteins (Abcam). For this reason, an antigen-retrieval step typically has to be included when 
using formalin-fixed paraffin-embedded tissue. Antigen retrieval can be performed by 
exposing the samples to heat or enzymes (Abcam).
9.1.3.3 Outgrowth Measurements and Colony-forming Efficiency Assay
Cell proliferative capacity was assessed by outgrowth measurements and a CFE assay. The 
outgrowth area in each culture is not merely a measure of the proliferative capacity of the 
growing cells, but also of the degree of cell migration and culture stratification. The 
outgrowth measurements in paper I should therefore not be taken as direct quantifications of 
proliferation. By looking at outgrowth instead of using more conventional proliferation 
assays, such as the MTT cell proliferation assay which is based on the reduction of the yellow 
tetrazolium salts by metabolically active cells (ATCC), we were able to exclude areas in the 
cultures covered with fibroblasts and concentrate on epithelial cell growth. In addition, we 
were able to compare directly the mm2 of primary culture obtained when using biopsies of 
different sizes and from different conjunctival regions. Such information is practically useful 
for surgeons attempting to cover a conjunctival defect of a given size.
 The CFE assay protocol used in paper I was based on that of Nakamura and co-
workers (2006a), who cultured the cells for no more than eight days. In addition to describing 
the CFE percentage, other groups have, based on colony size, differentiated between holo-, 
mero- and paraclone colonies (Barrandon and Green, 1987), where the former are considered 
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to rise from stem cells. Those groups, however, cultured the cells for almost two weeks, thus 
in paper I we were not able to detect any differences regarding the types of colonies grown 
from the different conjunctival regions. A longer culture period may have revealed differences 
between the groups.
9.1.3.4 Calcein-acetoxymethyl Ester/Ethidium Homodimer-1 Assay
Viability, demonstrated by a CAM/EH-1 assay (Invitrogen), was scored subjectively by 
blinded independent investigators. The CAM/EH-1 assay has the benefit of giving low 
background fluorescence as the CAM and EH-1 have to interact with the cell to become 
visibly fluorescent (Invitrogen). Calcein-acetoxymethyl is cell membrane permeable and 
enters the cytosol where it is enzymatically cleaved to the fluorescent calcein by esterases that 
are ubiquitously present in living cells (Poole et al., 1993). Calcein is retained by living cells, 
which become intensely green fluorescent. While EH-1 does not traverse the healthy cell 
membrane, cell membranes of dead cells, however, are widely permeable. Upon entering the 
cell, EH-1 reacts with nucleic acids to become 40-fold more fluorescent, after which the dead 
cell nucleus becomes intensely red fluorescent. 
9.2 Discussion of the Results
9.2.1 Effect of Explant and Culture Size on the Proliferative Conjunctival 
Cells
In paper I, the higher number of p63+ and PCNA+ (proliferative) cells in cultures from large 
explants may have been related to the finding that small explants yielded a relatively larger 
outgrowth area after eight days in culture. In split-skin transplantation, mincing of the split-
skin into smaller fragments has been shown to increase the fold growth without necessitating 
a longer growth period (Nanchahal, 1989), thus suggesting that smaller explants lead to faster 
outgrowth. As a result of a higher relative growth yield, cultured cells from small explants 
may have gone through more cell divisions at eight days in culture, compared with the large 
explants. Kolli et al. (2008) reported a loss of p63+ cells with increasing distance to the 
explants; in addition, the number of p63+ cells in the explant falls as the culture reaches 
confluence (Joseph et al., 2004). By day eight, cultured cells from the small explants might 
have gone through more cell divisions than cells from large explants, thereby reaching 
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senescence earlier and becoming p63– PCNA–. In paper I, we also reported higher p63 and 
PCNA expression in larger cultures. This could be explained by the findings: 1) of a positive 
correlation between explant size and culture size and 2) that large explants yield less fold 
growth after eight days ex vivo.
9.2.2 Proliferative Capacity of Conjunctival Epithelial Cells
Our results in paper I showing the highest outgrowth relative to explant size in forniceal 
cultures correspond to previous studies (Wei et al., 1993; Nizam et al., 2008). We also showed 
greater clonal growth capacity of the superior fornix. Few studies have investigated the 
difference between the superior and inferior conjunctiva with respect to proliferative or clonal 
growth capacity (Pellegrini et al., 1999). In contrast to our results, Pellegrini et al. (1999) 
concluded that similar CFE occurred in conjunctiva from the superior and inferior fornix and 
the four bulbar quadrants. The difference in findings might be explained by the fact that only 
one experiment with biopsies from a single human organ donor was employed and the CFE 
was higher in the superior fornix (18%) than in the inferior fornix (10%). 
9.2.3 Significance of Explant Size on Outgrowth
The finding that smaller explants yielded relatively more growth ex vivo may be of 
importance in improving culture protocols for conjunctival transplantation, as well as 
decreasing the donor site defects by necessitating less donor tissue. Ang et al. (2004; 2005) 
described an explant culture technique where they minced the conjunctival biopsies into small 
pieces (about 0.5 x 0.5 mm) before culturing. The technique of growing a single ocular 
surface transplant from numerous small explants has also been utilized successfully by others 
(Sangwan et al., 2003a; Sangwan et al., 2003b; Sangwan et al., 2005; Sangwan et al., 2006; 
Sangwan et al., 2011a; Basu et al., 2012). However, these authors did not investigate the 
significance of explant size on the cultured cells. The principle of dividing biopsy tissue to 
cover a larger wound area has long been used in split-skin transplantation (Tanner et al., 
1964). Using the mesh split-skin technique, between 1.5:1.0- to 6.0:1.0-fold expansion has 
been possible. This has been increased to a 20:1 expansion by mincing the epidermal biopsy 
into numerous smaller fragments (40 x 40 µm) (Nanchahal, 1989). Recently, Sangwan et al. 
reportedly necessitated less limbal donor tissue than with conventional limbal autografting 
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when adopting a novel technique involving transplantation of numerous small limbal 
epithelial explants (Sangwan et al., 2012). 
 The reason why small biopsies give relatively larger outgrowth may be hypothesized 
to result partly from the shorter average distance from the cut edge of the biopsy to the cells. 
Cytokine discharge from damaged epithelial cells can induce growth factor release from 
stromal fibroblasts (Li and Tseng, 1995). In skin biopsies, keratinocytes close to the cut edge 
show a shift toward the hyperproliferative phenotype (Komine et al., 2001).
9.2.4 Number of Goblet Cells with Regard to Conjunctival Region
9.2.4.1 In Vivo
Consistent with previous studies (Moore et al., 1987; Huang et al., 1988; Goller and 
Weyrauch, 1993; Lavker et al., 1998), the sections of whole rat eyes in paper II showed higher 
concentration of goblet cells, as indicated by CK7, UEA-1 and MUC5AC, in the forniceal 
regions than in the bulbar regions. In addition, the superior bulbar region had fewer goblet 
cells than the inferior bulbar region. A tendency for higher goblet cell concentration in the 
inferior conjunctiva compared to the superior (Moore et al., 1987) was reported for the first 
time in humans in 1910 (Virchow). The presence of a higher concentration of goblet cells in 
the inferior conjunctiva has been explained by the level of surface hydration (Kessing, 1968), 
which is increased in the lower lid sac due to the effect of gravity on the aqueous tear fluid 
(Moore et al., 1987).
9.2.4.2 Ex Vivo
In accordance with Nizam et al. (2008), in paper II we detected goblet cells in explant 
cultures originating from all conjunctival regions. In addition, we found that the densities of 
goblet cells in ex vivo cultures from specific locations in the conjunctiva corresponded with 
the location in sections from conjunctiva removed in vivo, with significantly more goblet cells 
in the forniceal cultures and least in superior bulbar cultures. Conjunctival transient 
amplifying cells are capable of differentiating into stratified epithelium and goblet cells 
(Pellegrini et al., 1999), which may suggest that forniceal explants contain the most 
progenitor cells committed to the goblet cell lineage. Moreover, it is well documented that 
goblet cells are able to proliferate in ex vivo culture (Shatos et al., 2001; Shatos et al., 2003; 
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Shatos et al., 2008). Thus, the higher percentage of goblet cells in forniceal cultures may also 
result from ex vivo proliferation of the larger quantity of goblet cells already present in the 
forniceal explants.
9.2.5 Phenotype with Regard to Location in Culture
9.2.5.1 Stratified Squamous, Non-goblet Epithelial Cells
Kolli et al. (2008) reported a progressively more differentiated limbal epithelium with 
increasing distance from the explant. In contrast, limbal cell cultures grown in the presence of 
feeder layer cells show undifferentiated cells mostly at the leading edge, while differentiated 
cells are found at the stratified center of the colonies (Meyer-Blazejewska et al., 2010). The 
latter study is in agreement with paper II showing stratified squamous epithelial cells (CK4+) 
present close to the explants, but absent close to the leading edge. 
9.2.5.2 Goblet Cells
Cytokeratin 7 is a secondary cytokeratin of simple epithelia, which can be upregulated in 
reactive conditions, including various types of injury such as inflammation or atrophy (Moll 
et al., 2008). Upregulation of CK7 is also seen in the stratified oral mucosal epithelium ex 
vivo, even though this epithelium is devoid of CK7 in vivo (Garzon et al., 2009). Thus, in 
paper II, the CK7+/UEA-1- cells at the leading edge in the primary cultures could represent 
cells with reactive upregulation of CK7 rather than true goblet cells. The density of CK7+ 
cells at the leading edge, on the other hand, showed significant positive correlation with the 
percentage of UEA-1+ goblet cells close to the explant in the same culture (data not shown). 
This suggests that the CK7+ cells at the leading edge were in fact related to the mucin-filled 
goblet cells. 
 In cases of LSCD with few goblet cells, detection of CK7+ cells can reportedly 
confirm conjunctival overgrowth of the cornea (Jirsova et al., 2011). That study, though, used 
a different anti-CK7 antibody clone (OV-TL 12/30) than we used in paper II, which stained all 
conjunctival cells and not specifically the goblet cells. In paper III, however, we employed the 
OV-TL 12/30 clone for CK7 detection. Similarly to Jirsova et al., this antibody clone 
demonstrated CK7 expression in all the cultured HCjE cells.
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 Although the migration pattern of stratified epithelia is not completely understood, 
corneal leading edge cells have been shown to become displaced to the apical epithelial layer 
as migration moves forward (Danjo and Gipson, 2002). If this migration pattern also applies 
for conjunctival epithelium, CK7+ cells at the leading edge are expected to be displaced to the 
apical layer during migration, thereafter possibly differentiating into mucin-filled goblet cells. 
Our finding that CK7+/UEA-1- cells, but not the CK7+/UEA-1+ cells, occasionally co-
express the putative stem cell marker ABCG2 could support this speculation. 
9.2.6 Goblet Cell Differentiation and Proliferative Capacity
The percentage of CK7+ cells ex vivo in paper II was similar in both large and small cultures, 
while the concentration of UEA-1+ cells was lowest in the large cultures. This could mean 
that the CK7+ goblet cells are more proliferative than the mucin-filled (UEA-1+) goblet cells 
or that mucin-production ceases during goblet cell migration from the explant. One could 
argue that the CK7+/UEA-1- cells growing from the explant have simply secreted their mucin 
granules and therefore are not less developed than the CK7+/UEA-1+ goblet cells. Still, the 
former cells would then not be expected to be more proliferative than the latter, as reported in 
our study.  The maintenance of a differentiated state is linked to cell cycle arrest and when 
stimulating post-mitotic ocular cells to proliferate, e.g. by exposing them to culture conditions 
with a medium containing FBS, the cells may lose some of their differentiated characteristics 
(Valtink and Engelmann, 2009). Transitory cell dedifferentiation initially during primary 
culture is typical of differentiated cells (MacDonald, 1994). 
 In paper II we used the same culture protocol as in previous reports that demonstrated 
mucin-producing goblet cells in both primary (Shatos et al., 2001; Shatos et al., 2003; 
Hayashi et al., 2012) and passaged cell culture (Shatos et al., 2001; Hayashi et al., 2012). 
Knowing that mucin-production can re-establish when passaging the cells using our culture 
protocol, we hypothesize that the loss of mucin-production during migration may represent 
temporary goblet cell dedifferentiation. Tracheal epithelial cells have been shown to briefly 
lose their mucin granules during the first phase of culture, apparently signalizing a transitory 
phase of dedifferentiation during cell proliferation (Wasano et al., 1988). The loss of mucin-
filled goblet cells during conjunctival cell migration has similarly been reported in studies on 
conjunctival wound healing (Friedenwald, 1951; Shapiro et al., 1981; Geggel et al., 1984). 
Collectively, these reports indicate that goblet cell mucin-production is temporarily halted 
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during the phase of migration/proliferation. The CK7+/UEA-1- cells might therefore 
represent immature goblet cells, i.e. goblet cells that can further develop into fully 
differentiated mucin-filled goblet cells. This finding may explain why proliferating goblet 
cells identified by their secretory product are difficult to detect in vivo. 
9.2.7 Conjunctival Niche
9.2.7.1 Phenotype of Cultured Cells
The higher percentage of mucin-filled goblet cells (UEA-1+ and MUC5AC+) close to the 
explant compared to near the leading edge may signify effects of different gradients of soluble 
or insoluble ECM proteins. The study by Meller and colleagues (2002) showing mucin-filled 
goblet cells after transplantation into Balb/c athymic mice may be an example of a niche 
effect. Others have showed that the composition of the BM and the ECM varies throughout 
the ocular surface (Schlotzer-Schrehardt et al., 2007). As we used explant culture in paper II, 
dissimilarities in the BM and ECM in each conjunctival harvesting site could have influenced 
the ex vivo phenotype. There were, however, no significant differences in the size of the 
explants obtained from the six conjunctival regions. Still, the relative distribution of 
subconjunctival tissue and epithelial cells in the explants was nevertheless unknown and 
variation in this distribution could also have affected the phenotype of the cultured 
conjunctival cells. Previous co-culture studies have shown that the specificities of the 
fibroblasts, as well as the FGF secreted by these cells, affect the amount of conjunctival 
progenitor and goblet cells (Tsai et al., 1994; Schrader et al., 2010; Ma et al., 2011). Hence, in 
paper II, the differentiation of goblet cells ex vivo could be partly related to the amount of 
subconjunctival tissue and the specific composition of the BM/ECM, in the explants.
9.2.7.2 Explant and Outgrowth Size
As the outgrowth measurements in paper I were performed on explant cultures, those 
measurements may have been affected by differences in the composition of the ECM in each 
conjunctival origin. Similarly, the outgrowth obtained from explants of different sizes may 
also have been related to the amount of growth-stimulating ECM components in each explant. 
A cell suspension approach could have normalized for such effects; however, we used the 
explant method for reasons mentioned in section 5.13.4.3.
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9.2.8 Morphology of Cultured Human Conjunctival Epithelial Cells after 
Storage
In paper III, the number of microvilli had largely disappeared after seven days of storage in 
Optisol-GS. As described in section 5.4.3, the microvilli/glycocalyx has an important role in 
promoting tear film stability and thereby a healthy ocular surface. Due to this, a decrease in 
the number of microvilli is undesired. A low number of microvilli is found in Sjögren’s 
syndrome (Koufakis et al., 2006) and Cennamo et al. (2008) demonstrated a direct correlation 
between the number of microvilli and the degree of tear film abnormalities and subjective 
sensation of dry eye. In our study, only storage for seven days in Optisol-GS showed a 
significant decrease in the number of microvilli compared to the unstored control. However, 
the mean number of microvilli had declined in all groups after storage. For instance, this 
number was approximately reduced by 50% in the four-day Optisol-GS storage group as well 
as in the seven-day HEPES-MEM storage group, compared to the HCjE cultures that were not  
stored. This suggests that the number of samples (n = 3-5), or the statistical power, were too 
low to obtain significance. Loss of microvilli is recognized as one of the early common events 
in various types of apoptosis (Kondo et al., 1997). In addition, a deficiency of nutrients has 
been speculated to cause alterations of the microvilli (Cennamo et al., 2008). 
 With respect to the number of cell layers, a significant decrease in this number was 
only observed in the seven-day HEPES-MEM storage group. However, it is worth noting that 
the number of cell layers had declined in all storage groups. The lack of significant results for 
these groups could be attributed to the low number of samples (n = 3-4). A decrease in the 
number of cell layers with time in culture has been reported with HLEC and oral mucosal 
cells, where the number was more than halved from day 15 to day 28 (Hayashi et al., 2010). 
Furthermore, reduction of epithelial thickness has been registered after organ culture storage 
of corneas at 37°C (Van Horn et al., 1975). 
 Storage for seven days demonstrated detachment of epithelial cells and detachment of 
the epithelia from the AM. Moreover, dilated intercellular spaces and an increase in the 
number of intracellular vacuoles were observed. We speculate that detachment of epithelial 
cells might be avoided or minimized by increasing cell stratification and enhancing the 
formation of cell-cell and cell-substrate adhesion by various techniques, such as denuding the 
AM, air-lifting and increasing the calcium concentration. However, any technique that 
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enhances stratification might simultaneously decrease the proliferative potential of the cells, 
thus reducing the long-term regenerative capability for cellular renewal. Consequently, a 
delicate balance is necessary. The use of a different substrate could also be a technique to 
enhance cell attachment (Tian et al., 2008).
9.2.9 Phenotype of Cultured Human Conjunctival Epithelial Cells after 
Storage
Numerous localizations, including the fornix, have been suggested for the conjunctival stem 
cells (Wei et al., 1993; Pellegrini et al., 1999; Wirtschafter et al., 1999), but no consensus has 
been reached. In paper III we cultured conjunctival tissue originating solely from the fornical 
region. After storage for four and seven days in both HEPES-MEM and Optisol-GS, positive 
immunostaining with several proposed stem/progenitor cell markers (ΔNp63α, ABCG2 and 
p63) was observed. No studies have reported immunostaining of cultured and stored HCjE 
cells, hence no data is available for direct comparison with our immunohistochemical 
findings. However, the results are in agreement with previous studies of short-and long-term 
eye bank storage of HLEC in serum-based media (Raeder et al., 2007b; Utheim et al., 2007; 
Utheim et al., 2009b) and serum-free media (Utheim et al., 2009a). 
 Raeder and colleagues (2007b) demonstrated that despite great variations in 
morphology of cultured HLEC due to different storage conditions for one week, the 
phenotype was still preserved. The expression of the proliferation markers Ki67 and PCNA 
was sustained during storage in both media. Preservation of Ki67 staining during storage of 
HLEC cultured on AM has been demonstrated previously by Utheim et al. (2007). While the 
number of PCNA positive epithelial cells has been reported to decrease with time in corneal 
organ culture (Gan et al., 1998), the retained PCNA and Ki-67 staining during storage in our 
study might have resulted from the use of AM as substrate, which contains mitogenic 
components, including growth factors. Freeze-dried AM, that might contain 50% lesser 
amount of EGF than non-freeze-dried AM, still induces significantly more PCNA positive 
corneal epithelial cells during healing of corneal ulcers, compared to application of contact 
lenses (Kim et al., 2009). 
 Interestingly, our culture and storage protocol resulted in immunoreactivity against the 
goblet cell markers CK7 and MUC5AC, but not against the stratified squamous marker CK4. 
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Investigators in other studies have demonstrated variable results, with some reports showing 
absence (Meller and Tseng, 1999; Ang et al., 2010) or presence (Wei et al., 1997) of goblet 
cells in cultured conjunctival epithelium. The variability in results may reflect the difference 
in goblet cell proliferation under various cell culture conditions. In addition, the use of the 
CK7 antibody clone OV-TL 12/30 in paper III, an antibody clone which in previous studies 
has stained all conjunctival cells (Jirsova et al., 2011), may not have been specific for goblet 
cells. 
9.2.10 Viability of Cultured Human Conjunctival Epithelial Cells after 
Storage
The viability in paper III was maintained at a high level throughout storage as indicated by 
few caspase-3 positive cells and a low percentage of EH-1 stained dead cells. These findings 
are consistent with a previous study on storage of cultured HLEC (Utheim et al., 2011). 
Hayashi et al. (2010) reported a drop in the viability of cultured HLEC and oral mucosal cells 
from 93.2% to 64.1% from day 15 to day 28. Our studies and their study are not directly 
comparable due to the differences in the culture protocol and cell type. However, their finding 
suggests that a reduction in viability could be expected with increasing time in storage.
9.3 Strengths and Limitations of the Studies
9.3.1 Study Designs
All studies were designed as randomized controlled trials, thereby enabling inferences 
regarding causality. However, the studies are generally based on small samples, thus caution 
should be exercised when generalizing the data to a wider population. Small sample studies 
could be especially problematic when describing equality between groups, such as between 
the control cells and stored tissue in paper III. However, although possible significant results 
are missed due to an underpowered study, the lack of large effects is still demonstrated.
9.3.2 Analyses
In all studies, the comparisons of expressed proteins were subjectively assessed. To lessen the 
chance of observer bias two independent investigators blinded to the origin of the material 
performed the analyses. Although supplemental methods, such as Western blot (WB) would 
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have strengthened the quantification of expressed proteins, the use of ICC/IHC had some 
advantages. In paper II, the rat primary cultures were generally small, yielding little amount 
of tissue. In this case ICC, which in contrast to WB necessitates only a small number of cells, 
was chosen to assess differences in expressed proteins between the groups. Detection of co-
expressed proteins in single cells in paper I also required the use of ICC compared to WB and 
PCR analyses. Assessment of the agreement between the two independent investigators 
confirmed high reliability of the phenotypic data. Thus, although a subjective method for 
quantifying proteins, ICC was indispensable for that paper and produced reliable results.
9.3.3 Generalizability of the Results
The studies have been performed using two different sources of conjunctival epithelial cells. 
The first two studies utilized rat conjunctival tissue, thus the results are not directly 
transferable to humans. However, rat conjunctival epithelial cells are an excellent alternative 
to human conjunctiva due, amongst other reasons, to lack of available human tissue and the 
high biological similarity between rat and human conjunctival epithelium (Dartt et al., 2011). 
Biological variations are also likely to be smaller between rats of the same age that are bred 
under defined conditions than between human donors. The third study took use of human 
donor tissue instead of rat tissue and, therefore, possibly leading to larger biological variation 
between the samples. The tissues were obtained from Centro de Oftalmologia de Barraquer in 
Barcelona where a local surgeon was responsible for the tissue harvesting. There may 
therefore have been some variation in biopsy harvesting site to which we were unaware. 
Judging from the results of study I and II, such variations could have had effects on the 
phenotype and proliferative ability of the cultured cells in paper III. Using human donor tissue 
however, has the obvious strength of being more clinically relevant. 
9.4 Ethics
9.4.1 Use of Animal Tissues
The Schepens Eye Research Institute (SERI) Animal Care and Use Committee approved the 
two studies employing rat conjunctival tissue. In addition, all removal of tissue and 
subsequent manipulations of animals conformed to the guidelines established by the 
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Association for Research in Vision and Ophthalmology (ARVO) Statement for the Use of 
Animals in Ophthalmic and Vision Research. 
9.4.2 Use of Human Donor Tissues
Study three was approved by The South-Eastern Norway Regional Committee for Medical 
Research Ethics (REC) and was reported to the Biobank Registry. Human conjunctival tissue 
was obtained with research consent from the Institut Universitari Barraquer/Universitat 
Autonoma de Barcelona (Barcelona, Spain) and human AM was obtained with research 
consent from the Department of Obstetrics and Gynecology, Oslo University Hospital (OUH), 
Ulleval. All human tissues were used in accordance with the Declaration of Helsinki. Tissue 
and the information derived from all samples are stored in a specific biobank at OUH 
(biobank 2010/1022). Wenche Reed is responsible for the biobank, but in daily practice, 
project manager Torstein Lyberg can be contacted regarding practical questions. The biobank 
is planned to last until 2018. After this, material and information will be destroyed / deleted 
according to internal guidelines.
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10. FUTURE PERSPECTIVES
10.1 Culture of Conjunctival Epithelial Cells
More work needs to be done to establish the optimal harvesting site for conjunctival epithelial 
progenitor cells. Although several reports conclude that fornix is the best location for 
collecting conjunctival cells, this should be proven in clinical studies with human donors. 
Moreover, the optimal harvesting site for transplanting goblet cells should also be explored 
using human cells as this so far has not been investigated.
10.2 Storage of Conjunctival Epithelial Cells
Our study showing that HCjE cells can be stored for at least four days on AM warrants further 
animal/clinical studies to demonstrate that the HCjE cells show continued survival in the 
recipient’s eye. The effect of storage temperature needs also be further elaborated by culturing 
cells stored at different temperatures to look for changes in proliferative capacity, degree of 
differentiation and cell damage.
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11. CONCLUSIONS
11.1 General Conclusion
Small forniceal conjunctival explants grow the most effectively; however, for transplantation 
purposes, the loss of p63+ and PCNA+ cells with small explants must be considered. 
Forniceal explants yield the highest number of goblet cells ex vivo and thereby seem to be 
optimal for goblet cell transplantation. In addition, we suggest that CK7+/UEA-1- cells 
represent highly proliferative immature goblet cells that might have the capacity to develop 
into mucin-filled goblet cells. The CK7+/UEA-1- cells may be of importance during 
conjunctival migration as they are mostly located close to the leading edge and their density 
does not decrease with increasing outgrowth size. Cultured HCjE cells may be subjected to 
storage for at least four days in serum-free HEPES-MEM at 23°C. Knowledge regarding 
conjunctival epithelial cell response during serum-free storage conditions may aid in the 
process of developing methods for ocular surface reconstruction. 
11.2 Conclusions of the Individual Papers
Paper I We concluded that forniceal explants appeared the most proliferative and 
thereby seem to be optimal for conjunctival epithelial cell transplantation. The 
use of small, rather than large, explants is most effective for ex vivo expansion, 
potentially resulting in smaller donor site defects. The loss of p63+ and PCNA
+ cells when using small explants must be taken into consideration, however, 
favoring the use of larger explants.
Paper II We conclude that forniceal explants yield the highest number of goblet cells ex 
vivo and thereby seem to be optimal for goblet cell transplantation. We also 
suggest that CK7+/UEA-1- cells represent highly proliferative immature goblet 
cells. These cells could be important during conjunctival migration as they are 
mostly located close to the leading edge and their density does not decrease 
with increasing outgrowth size.
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Paper III We concluded that the phenotype and viability of HCjE cells cultured for two 
weeks were preserved during subsequent storage for seven days in serum-free 
HEPES-MEM and Optisol-GS. The number of epithelial microvilli and cell 
layers showed a decreasing tendency with time during storage. Thus, cultured 
HCjE cells appear to be preserved in serum-free storage media at 23°C for at 
least four days.
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12. ERRATA
Paper III, section 2.2.: The concentrations of insulin and transferrin were 5 µg/mL.
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